Bank of Nova Scotia increased its stake in shares of NiSource, Inc (NYSE:NI – Free Report) by 243.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 673,457 shares of the utilities provider’s stock after acquiring an additional 477,187 shares during the quarter. Bank of Nova Scotia owned about 0.14% of NiSource worth $31,424,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. NewEdge Advisors LLC increased its position in shares of NiSource by 60.1% during the first quarter. NewEdge Advisors LLC now owns 30,494 shares of the utilities provider’s stock worth $1,223,000 after purchasing an additional 11,452 shares in the last quarter. Woodline Partners LP increased its position in NiSource by 41.6% during the first quarter. Woodline Partners LP now owns 39,703 shares of the utilities provider’s stock worth $1,592,000 after buying an additional 11,671 shares during the period. Acadian Asset Management LLC acquired a new position in shares of NiSource in the 1st quarter valued at $105,000. AXA S.A. purchased a new stake in shares of NiSource in the second quarter valued at about $1,054,000. Finally, Squarepoint Ops LLC boosted its stake in shares of NiSource by 27.6% during the second quarter. Squarepoint Ops LLC now owns 207,409 shares of the utilities provider’s stock worth $8,367,000 after buying an additional 44,822 shares during the period. 91.64% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In NI has been the topic of a number of research reports. Royal Bank Of Canada assumed coverage on NiSource in a report on Wednesday, July 1st. They set an “outperform” rating and a $52.00 price target on the stock. Wells Fargo & Company increased their price objective on NiSource from $51.00 to $52.00 and gave the stock an “overweight” rating in a research report on Thursday, May 7th. Weiss Ratings reissued a “buy (b)” rating on shares of NiSource in a report on Tuesday. Evercore set a $52.00 price target on NiSource in a research note on Monday, May 11th. Finally, Wall Street Zen lowered shares of NiSource from a “hold” rating to a “sell” rating in a research report on Saturday, May 16th. Nine equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $50.30.
Get Our Latest Stock Analysis on NI
Insider Activity In related news, EVP Melody Birmingham sold 2,500 shares of the company’s stock in a transaction on Wednesday, May 20th. The stock was sold at an average price of $47.43, for a total value of $118,575.00. Following the completion of the transaction, the executive vice president directly owned 116,036 shares in the company, valued at approximately $5,503,587.48. This represents a 2.11% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Melanie B. Berman sold 15,000 shares of the stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $47.68, for a total value of $715,200.00. Following the transaction, the executive vice president owned 35,990 shares in the company, valued at $1,716,003.20. This trade represents a 29.42% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 27,500 shares of company stock worth $1,305,675 over the last ninety days. 0.37% of the stock is owned by corporate insiders.
NiSource Trading Down 0.2% Shares of NI opened at $46.66 on Friday. The company has a debt-to-equity ratio of 1.30, a current ratio of 0.65 and a quick ratio of 0.56. NiSource, Inc has a 1-year low of $38.45 and a 1-year high of $49.21. The stock has a market cap of $22.37 billion, a price-to-earnings ratio of 23.21, a price-to-earnings-growth ratio of 3.48 and a beta of 0.55. The firm has a 50 day simple moving average of $46.90 and a 200-day simple moving average of $46.26.
NiSource (NYSE:NI – Get Free Report) last announced its earnings results on Wednesday, May 6th. The utilities provider reported $1.06 EPS for the quarter, meeting analysts’ consensus estimates of $1.06. NiSource had a return on equity of 8.31% and a net margin of 14.15%.The firm had revenue of $2.36 billion for the quarter, compared to analysts’ expectations of $2.52 billion. During the same quarter in the prior year, the firm earned $0.85 EPS. NiSource has set its FY 2026 guidance at 2.020-2.070 EPS. Equities analysts forecast that NiSource, Inc will post 2.05 EPS for the current fiscal year.
NiSource Dividend Announcement The company also recently announced a quarterly dividend, which will be paid on Thursday, August 20th. Shareholders of record on Friday, July 31st will be issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 2.6%. The ex-dividend date is Friday, July 31st. NiSource’s dividend payout ratio is 59.70%.
Key Stories Impacting NiSource Here are the key news stories impacting NiSource this week:
Positive Sentiment: KeyCorp kept an Overweight rating on NiSource and reiterated a $50 price target, implying upside from current levels and signaling continued analyst confidence in the utility’s valuation. Benzinga report Positive Sentiment: KeyCorp raised its FY2027, FY2028, and FY2029 EPS estimates for NiSource, suggesting improving earnings power over the next several years and supporting the stock’s longer-term investment case. Positive Sentiment: Wells Fargo reportedly initiated or maintained a Buy view on NiSource, adding to the positive analyst backdrop around the stock. Nisource (NI) Gets a Buy from Wells Fargo Neutral Sentiment: KeyCorp trimmed near-term EPS estimates for Q2, Q3, and Q4 2026, which may temper enthusiasm somewhat, but the reductions were relatively small and did not change the firm’s overall positive stance. Neutral Sentiment: Consensus full-year earnings remain at about $2.05 per share, so the latest analyst revisions do not materially alter the broad earnings outlook yet. NiSource Profile (Free Report)
NiSource, Inc (NYSE: NI) is a publicly traded energy holding company headquartered in Merrillville, Indiana, that primarily owns and operates regulated local gas and electric utilities in the United States. Through its operating subsidiaries, the company delivers natural gas and electricity to residential, commercial and industrial customers and provides the associated distribution and transmission services that keep local energy systems functioning.
The company’s core activities include natural gas distribution, electric transmission and distribution, system operations, maintenance and emergency response.
Read More Five stocks we like better than NiSource AMD and Cerbras Create A New Blueprint For Hardware Intel Earnings Reveal Whether the Chip Selloff Created a Buy CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test Plugging In: How Kinder Morgan Powers Up Profits Want to see what other hedge funds are holding NI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NiSource, Inc (NYSE:NI – Free Report).
Receive News & Ratings for NiSource Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NiSource and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINESomnigroup International Inc. $SGI Shares Sold by Beaconlight Capital LLC
Assetmark Inc. reduced its position in shares of Hershey Company (The) (NYSE:HSY – Free Report) by 60.9% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 6,396 shares of the company’s stock after selling 9,955 shares during the quarter. Assetmark Inc.’s holdings in Hershey were worth $1,330,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also bought and sold shares of the company. JPL Wealth Management LLC bought a new position in Hershey in the third quarter worth about $26,000. Reflection Asset Management purchased a new position in Hershey in the fourth quarter valued at $26,000. Bard Associates Inc. purchased a new position in Hershey during the fourth quarter worth approximately $26,000. Laurel Wealth Advisors LLC purchased a new position in shares of Hershey during the 4th quarter valued at approximately $27,000. Finally, Manchester Capital Management LLC lifted its stake in Hershey by 123.0% in the 4th quarter. Manchester Capital Management LLC now owns 165 shares of the company’s stock valued at $30,000 after buying an additional 91 shares in the last quarter. 57.96% of the stock is owned by institutional investors.
Insider Activity In related news, CFO Steven E. Voskuil sold 1,500 shares of the business’s stock in a transaction on Thursday, June 18th. The shares were sold at an average price of $173.43, for a total value of $260,145.00. Following the sale, the chief financial officer directly owned 54,695 shares of the company’s stock, valued at approximately $9,485,753.85. The trade was a 2.67% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.08% of the company’s stock.
Analysts Set New Price Targets A number of equities analysts recently commented on the company. Deutsche Bank Aktiengesellschaft reduced their price objective on Hershey from $212.00 to $200.00 and set a “hold” rating on the stock in a research report on Monday, March 30th. Jefferies Financial Group set a $190.00 price objective on shares of Hershey in a report on Thursday, July 16th. Evercore set a $225.00 price objective on shares of Hershey in a research report on Thursday. Bank of America lowered their price objective on shares of Hershey from $220.00 to $200.00 and set a “neutral” rating on the stock in a research note on Thursday, June 25th. Finally, The Goldman Sachs Group set a $240.00 target price on Hershey in a research report on Friday, May 1st. Seven equities research analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the company. According to data from MarketBeat, Hershey currently has an average rating of “Hold” and a consensus target price of $208.28.
Get Our Latest Stock Report on Hershey
Hershey Stock Performance Shares of NYSE HSY opened at $174.43 on Friday. The company has a market cap of $35.38 billion, a P/E ratio of 32.48, a P/E/G ratio of 1.07 and a beta of 0.11. Hershey Company has a 12 month low of $161.43 and a 12 month high of $239.48. The business’s 50 day moving average is $180.34 and its two-hundred day moving average is $196.79. The company has a quick ratio of 0.77, a current ratio of 1.24 and a debt-to-equity ratio of 0.99.
Hershey (NYSE:HSY – Get Free Report) last issued its earnings results on Thursday, April 30th. The company reported $2.35 EPS for the quarter, topping the consensus estimate of $2.04 by $0.31. Hershey had a return on equity of 28.98% and a net margin of 9.12%.The firm had revenue of $3.10 billion during the quarter, compared to analysts’ expectations of $3.03 billion. During the same period last year, the business earned $2.09 earnings per share. Hershey’s quarterly revenue was up 10.7% compared to the same quarter last year. On average, equities analysts expect that Hershey Company will post 8.42 EPS for the current year.
Hershey Announces Dividend The company also recently announced a quarterly dividend, which was paid on Monday, June 15th. Shareholders of record on Friday, May 15th were issued a $1.452 dividend. The ex-dividend date was Friday, May 15th. This represents a $5.81 annualized dividend and a yield of 3.3%. Hershey’s dividend payout ratio (DPR) is 108.19%.
Hershey Profile (Free Report)
The Hershey Company (NYSE: HSY) is a leading North American chocolatier and snack manufacturer headquartered in Hershey, Pennsylvania. The company develops, produces and markets a wide range of confectionery and snack products for retail, foodservice and international customers. Hershey’s business spans manufacturing, branded product marketing, packaging and distribution across grocery, convenience, mass merchant and e-commerce channels.
Hershey’s product portfolio centers on chocolate and sugar confectionery, including core brands such as Hershey’s, Reese’s, Hershey’s Kisses and Twizzlers, alongside non-chocolate snacks and confectionery brands.
Recommended Stories Five stocks we like better than Hershey AMD and Cerbras Create A New Blueprint For Hardware Intel Earnings Reveal Whether the Chip Selloff Created a Buy CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test Plugging In: How Kinder Morgan Powers Up Profits Want to see what other hedge funds are holding HSY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hershey Company (The) (NYSE:HSY – Free Report).
Receive News & Ratings for Hershey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hershey and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEAllspring Global Investments Holdings LLC Has $3.86 Million Stock Position in Patrick Industries, Inc. $PATK
NEXT HEADLINE »Andra AP fonden Acquires 323,393 Shares of Broadcom Inc. $AVGO
Affinity Asset Advisors LLC lifted its stake in shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 185.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 200,000 shares of the biotechnology company’s stock after acquiring an additional 130,000 shares during the quarter. Affinity Asset Advisors LLC owned about 0.14% of Arrowhead Pharmaceuticals worth $12,540,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently added to or reduced their stakes in ARWR. Tsfg LLC acquired a new stake in shares of Arrowhead Pharmaceuticals during the 4th quarter valued at $25,000. iSAM Funds UK Ltd bought a new stake in Arrowhead Pharmaceuticals during the third quarter worth approximately $29,000. First Horizon Corp acquired a new stake in shares of Arrowhead Pharmaceuticals in the fourth quarter worth $32,000. WPG Advisers LLC lifted its stake in shares of Arrowhead Pharmaceuticals by 384.8% in the fourth quarter. WPG Advisers LLC now owns 543 shares of the biotechnology company’s stock worth $36,000 after buying an additional 431 shares during the last quarter. Finally, Hantz Financial Services Inc. boosted its holdings in shares of Arrowhead Pharmaceuticals by 177.1% during the 4th quarter. Hantz Financial Services Inc. now owns 737 shares of the biotechnology company’s stock worth $49,000 after buying an additional 471 shares during the period. 62.61% of the stock is currently owned by institutional investors and hedge funds.
Arrowhead Pharmaceuticals Stock Down 1.4% Shares of NASDAQ ARWR opened at $85.60 on Friday. The stock has a market capitalization of $12.06 billion, a P/E ratio of -39.81 and a beta of 1.26. The stock’s fifty day moving average is $77.94 and its 200 day moving average is $69.97. Arrowhead Pharmaceuticals, Inc. has a 52 week low of $15.01 and a 52 week high of $95.49. The company has a debt-to-equity ratio of 1.41, a quick ratio of 6.23 and a current ratio of 6.23.
Arrowhead Pharmaceuticals (NASDAQ:ARWR – Get Free Report) last released its earnings results on Thursday, May 7th. The biotechnology company reported ($0.93) EPS for the quarter, beating the consensus estimate of ($1.10) by $0.17. The firm had revenue of $73.74 million for the quarter, compared to analyst estimates of $73.84 million. Arrowhead Pharmaceuticals had a negative net margin of 48.38% and a negative return on equity of 55.09%. The business’s quarterly revenue was down 86.4% compared to the same quarter last year. During the same period last year, the firm earned $2.75 EPS. Sell-side analysts forecast that Arrowhead Pharmaceuticals, Inc. will post -3.08 earnings per share for the current fiscal year.
Insider Activity at Arrowhead Pharmaceuticals In related news, Director Hongbo Lu sold 2,970 shares of the firm’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $76.88, for a total transaction of $228,333.60. Following the completion of the sale, the director owned 52,012 shares of the company’s stock, valued at $3,998,682.56. This trade represents a 5.40% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 3.60% of the stock is currently owned by insiders.
Analysts Set New Price Targets A number of brokerages have issued reports on ARWR. Morgan Stanley lifted their price objective on Arrowhead Pharmaceuticals from $100.00 to $120.00 and gave the company an “overweight” rating in a report on Thursday. JPMorgan Chase & Co. lifted their price target on shares of Arrowhead Pharmaceuticals from $88.00 to $95.00 and gave the company an “overweight” rating in a report on Friday, July 17th. Sanford C. Bernstein boosted their price target on shares of Arrowhead Pharmaceuticals from $35.00 to $46.00 and gave the company a “market perform” rating in a research report on Wednesday, May 13th. Royal Bank Of Canada upped their price objective on shares of Arrowhead Pharmaceuticals from $80.00 to $87.00 and gave the stock an “outperform” rating in a research note on Friday, May 8th. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $126.00 price objective (up from $110.00) on shares of Arrowhead Pharmaceuticals in a report on Thursday. One analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Arrowhead Pharmaceuticals currently has a consensus rating of “Moderate Buy” and an average target price of $93.83.
Get Our Latest Stock Analysis on ARWR
Arrowhead Pharmaceuticals Company Profile (Free Report)
Arrowhead Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics. Since its founding in 2008, Arrowhead has leveraged its proprietary delivery platform—known internally as the Advanced RNAi Compound (ARC) technology—to silence disease-causing genes in patients suffering from genetically defined diseases. The company’s approach aims to offer durable, targeted treatments across a range of therapeutic areas.
The company’s pipeline includes multiple candidates in various stages of development.
Featured Articles Five stocks we like better than Arrowhead Pharmaceuticals AMD and Cerbras Create A New Blueprint For Hardware Intel Earnings Reveal Whether the Chip Selloff Created a Buy CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test Plugging In: How Kinder Morgan Powers Up Profits Want to see what other hedge funds are holding ARWR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report).
Receive News & Ratings for Arrowhead Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arrowhead Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEESCO Technologies Inc. $ESE Shares Sold by Allspring Global Investments Holdings LLC
NEXT HEADLINE »Arrowstreet Capital Limited Partnership Sells 1,504,237 Shares of Johnson & Johnson $JNJ
Bank of New York Mellon Corp raised its stake in shares of Amkor Technology, Inc. (NASDAQ:AMKR – Free Report) by 1.8% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 983,987 shares of the semiconductor company’s stock after acquiring an additional 16,995 shares during the period. Bank of New York Mellon Corp owned about 0.40% of Amkor Technology worth $44,309,000 as of its most recent SEC filing.
Other hedge funds have also recently bought and sold shares of the company. IFP Advisors Inc increased its stake in Amkor Technology by 91.2% in the 3rd quarter. IFP Advisors Inc now owns 937 shares of the semiconductor company’s stock valued at $27,000 after buying an additional 447 shares during the last quarter. Smartleaf Asset Management LLC lifted its position in shares of Amkor Technology by 180.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 684 shares of the semiconductor company’s stock worth $28,000 after buying an additional 440 shares in the last quarter. Root Financial Partners LLC boosted its stake in shares of Amkor Technology by 38.8% in the 4th quarter. Root Financial Partners LLC now owns 937 shares of the semiconductor company’s stock worth $37,000 after buying an additional 262 shares during the last quarter. Advisors Asset Management Inc. grew its holdings in shares of Amkor Technology by 61.8% in the first quarter. Advisors Asset Management Inc. now owns 2,236 shares of the semiconductor company’s stock valued at $40,000 after acquiring an additional 854 shares in the last quarter. Finally, State of Wyoming bought a new position in shares of Amkor Technology in the fourth quarter valued at approximately $41,000. 42.76% of the stock is owned by hedge funds and other institutional investors.
Amkor Technology News Roundup Here are the key news stories impacting Amkor Technology this week:
Positive Sentiment: Amkor announced a multi-year partnership with NVIDIA worth $1.5 billion to expand advanced semiconductor packaging and test capacity in the U.S., a significant boost to its AI-related growth outlook. Reuters article Positive Sentiment: NVIDIA will provide a prepayment to help fund the expansion, which may reduce near-term capital burden while accelerating capacity buildout for next-generation AI packaging. Business Wire article Positive Sentiment: UBS upgraded Amkor Technology from neutral to buy and set a $90 price target, signaling improved analyst confidence in the company’s upside after the NVIDIA deal. The Fly article Neutral Sentiment: Short-interest data showed no meaningful shares reported, so it does not appear to be adding a clear bearish or bullish signal for the stock right now. Neutral Sentiment: Some commentary noted that Amkor’s long-term investment case still depends on margin expansion and successful execution on advanced packaging projects, including its Arizona facility and other strategic growth initiatives. Seeking Alpha article Negative Sentiment: B. Riley Financial lowered its price target to $75, suggesting some analysts still see valuation or execution risk despite the recent rally. American Banking News article Analyst Upgrades and Downgrades AMKR has been the topic of several research analyst reports. Needham & Company LLC boosted their price objective on Amkor Technology from $65.00 to $90.00 and gave the stock a “buy” rating in a research report on Tuesday, April 28th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Amkor Technology in a research report on Friday, July 17th. UBS Group upgraded Amkor Technology from a “neutral” rating to a “buy” rating and set a $90.00 target price on the stock in a research note on Friday. Zacks Research upgraded shares of Amkor Technology from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 20th. Finally, B. Riley Financial decreased their price objective on shares of Amkor Technology from $90.00 to $75.00 and set a “neutral” rating for the company in a report on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $69.25.
Check Out Our Latest Stock Analysis on AMKR
Insider Buying and Selling at Amkor Technology In other news, Director Gil C. Tily sold 15,000 shares of the firm’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $77.30, for a total transaction of $1,159,500.00. Following the sale, the director owned 108,806 shares in the company, valued at approximately $8,410,703.80. This trade represents a 12.12% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Mark N. Rogers sold 5,000 shares of Amkor Technology stock in a transaction dated Tuesday, June 16th. The stock was sold at an average price of $86.21, for a total value of $431,050.00. Following the sale, the executive vice president directly owned 38,904 shares of the company’s stock, valued at approximately $3,353,913.84. This trade represents a 11.39% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 114,000 shares of company stock valued at $8,631,450 over the last quarter. Company insiders own 26.40% of the company’s stock.
Amkor Technology Price Performance Shares of NASDAQ AMKR opened at $64.96 on Friday. Amkor Technology, Inc. has a fifty-two week low of $20.86 and a fifty-two week high of $96.68. The stock has a market cap of $16.10 billion, a PE ratio of 37.12 and a beta of 2.20. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.74 and a current ratio of 2.01. The stock has a fifty day moving average of $73.36 and a 200-day moving average of $60.67.
Amkor Technology (NASDAQ:AMKR – Get Free Report) last released its quarterly earnings data on Monday, April 27th. The semiconductor company reported $0.33 EPS for the quarter, beating analysts’ consensus estimates of $0.23 by $0.10. The company had revenue of $1.68 billion during the quarter, compared to analyst estimates of $1.63 billion. Amkor Technology had a net margin of 6.17% and a return on equity of 9.88%. Amkor Technology’s revenue was up 27.5% compared to the same quarter last year. During the same period last year, the business earned $0.09 earnings per share. Equities research analysts anticipate that Amkor Technology, Inc. will post 2.08 earnings per share for the current year.
Amkor Technology Announces Dividend The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 23rd. Stockholders of record on Wednesday, June 3rd were given a dividend of $0.0835 per share. This represents a $0.33 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date was Wednesday, June 3rd. Amkor Technology’s dividend payout ratio (DPR) is 18.86%.
Amkor Technology Company Profile (Free Report)
Amkor Technology, Inc (NASDAQ:AMKR) is a leading provider of outsourced semiconductor packaging and test (OSAT) services, supporting integrated device manufacturers and semiconductor foundries worldwide. The company offers a broad range of advanced packaging solutions, including wafer bumping, flip chip, system-in-package and ball grid array technologies, designed to meet the performance, power and form-factor demands of applications across consumer electronics, automotive, communications and industrial markets.
In addition to packaging, Amkor delivers comprehensive test services such as wafer probing, final test, system-level test and digital, analog and mixed-signal testing, enabling customers to accelerate time-to-market and reduce total costs.
Read More Five stocks we like better than Amkor Technology AMD and Cerbras Create A New Blueprint For Hardware Intel Earnings Reveal Whether the Chip Selloff Created a Buy CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test Plugging In: How Kinder Morgan Powers Up Profits Want to see what other hedge funds are holding AMKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amkor Technology, Inc. (NASDAQ:AMKR – Free Report).
Receive News & Ratings for Amkor Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amkor Technology and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEa16z Perennial Management L.P. Trims Holdings in Alphabet Inc. $GOOG
NEXT HEADLINE »Bellwether Advisors LLC Has $4.08 Million Stock Position in Alphabet Inc. $GOOG
Bank of Nova Scotia grew its holdings in shares of ATI Inc. (NYSE:ATI – Free Report) by 92.9% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 467,149 shares of the basic materials company’s stock after buying an additional 224,949 shares during the quarter. Bank of Nova Scotia owned 0.34% of ATI worth $67,951,000 at the end of the most recent quarter.
A number of other hedge funds have also made changes to their positions in the business. Meeder Asset Management Inc. grew its stake in shares of ATI by 2.8% in the first quarter. Meeder Asset Management Inc. now owns 2,754 shares of the basic materials company’s stock valued at $401,000 after buying an additional 74 shares in the last quarter. Lido Advisors LLC grew its position in ATI by 2.7% in the third quarter. Lido Advisors LLC now owns 3,784 shares of the basic materials company’s stock valued at $308,000 after acquiring an additional 101 shares in the last quarter. Signature Equity Partners LLC grew its position in ATI by 208.5% in the first quarter. Signature Equity Partners LLC now owns 182 shares of the basic materials company’s stock valued at $26,000 after acquiring an additional 123 shares in the last quarter. Activest Wealth Management raised its stake in shares of ATI by 17.6% during the fourth quarter. Activest Wealth Management now owns 834 shares of the basic materials company’s stock valued at $96,000 after purchasing an additional 125 shares during the period. Finally, D.A. Davidson & CO. lifted its position in shares of ATI by 2.0% during the fourth quarter. D.A. Davidson & CO. now owns 7,202 shares of the basic materials company’s stock worth $827,000 after purchasing an additional 140 shares in the last quarter.
Insider Buying and Selling at ATI In related news, CEO Kimberly A. Fields sold 59,749 shares of the company’s stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $179.07, for a total transaction of $10,699,253.43. Following the transaction, the chief executive officer directly owned 218,014 shares of the company’s stock, valued at approximately $39,039,766.98. The trade was a 21.51% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders sold a total of 160,442 shares of company stock worth $28,535,831 in the last quarter. Insiders own 0.98% of the company’s stock.
ATI Stock Performance ATI opened at $197.47 on Friday. The business has a 50 day moving average price of $185.32 and a two-hundred day moving average price of $159.20. ATI Inc. has a 1-year low of $70.42 and a 1-year high of $205.31. The company has a market capitalization of $26.95 billion, a price-to-earnings ratio of 65.39, a price-to-earnings-growth ratio of 1.59 and a beta of 0.96. The company has a debt-to-equity ratio of 0.95, a current ratio of 2.67 and a quick ratio of 1.17.
ATI (NYSE:ATI – Get Free Report) last released its earnings results on Thursday, April 30th. The basic materials company reported $1.00 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.88 by $0.12. ATI had a return on equity of 26.44% and a net margin of 9.26%.The firm had revenue of $1.15 billion for the quarter, compared to analyst estimates of $1.19 billion. During the same period in the previous year, the company earned $0.72 earnings per share. ATI’s revenue was up .6% compared to the same quarter last year. ATI has set its Q2 2026 guidance at 0.980-1.040 EPS and its FY 2026 guidance at 4.200-4.480 EPS. Research analysts predict that ATI Inc. will post 4.49 EPS for the current fiscal year.
Analysts Set New Price Targets A number of equities research analysts recently weighed in on the stock. Susquehanna raised their price target on shares of ATI from $185.00 to $215.00 and gave the company a “positive” rating in a report on Thursday, July 9th. Wells Fargo & Company initiated coverage on shares of ATI in a research report on Wednesday, April 1st. They issued an “overweight” rating and a $175.00 price objective for the company. BTIG Research lifted their target price on ATI from $165.00 to $180.00 and gave the stock a “buy” rating in a research report on Friday, May 1st. Wall Street Zen upgraded ATI from a “hold” rating to a “buy” rating in a research note on Monday, July 20th. Finally, Zacks Research raised ATI from a “hold” rating to a “strong-buy” rating in a report on Thursday, June 25th. Two equities research analysts have rated the stock with a Strong Buy rating and nine have issued a Buy rating to the company’s stock. According to data from MarketBeat.com, ATI currently has a consensus rating of “Buy” and an average price target of $176.78.
View Our Latest Stock Report on ATI
About ATI (Free Report)
Allegheny Technologies Incorporated (ATI) is a global manufacturer of specialty materials and complex components, serving aerospace, defense, oil and gas, chemical processing, medical and other industrial end markets. The company operates through two main segments: High Performance Materials & Components, which produces titanium and nickel-based alloys, stainless and specialty steels, and precision forgings; and Flat-Rolled Products, which supplies stainless steel, nickel and specialty alloy sheet, strip and precision-rolled plate.
Featured Articles Five stocks we like better than ATI AMD and Cerbras Create A New Blueprint For Hardware Intel Earnings Reveal Whether the Chip Selloff Created a Buy CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test Plugging In: How Kinder Morgan Powers Up Profits Want to see what other hedge funds are holding ATI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ATI Inc. (NYSE:ATI – Free Report).
Receive News & Ratings for ATI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ATI and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEMobileye Global (NASDAQ:MBLY) Price Target Lowered to $7.00 at Royal Bank Of Canada
NEXT HEADLINE »Bank of Nova Scotia Sells 171,071 Shares of T-Mobile US, Inc. $TMUS
Assetmark Inc. cut its stake in Builders FirstSource, Inc. (NYSE:BLDR – Free Report) by 96.6% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 20,319 shares of the company’s stock after selling 572,885 shares during the quarter. Assetmark Inc.’s holdings in Builders FirstSource were worth $1,673,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Cromwell Holdings LLC boosted its position in Builders FirstSource by 1,323.5% during the 4th quarter. Cromwell Holdings LLC now owns 242 shares of the company’s stock valued at $25,000 after acquiring an additional 225 shares in the last quarter. Caitong International Asset Management Co. Ltd boosted its position in shares of Builders FirstSource by 167.1% during the third quarter. Caitong International Asset Management Co. Ltd now owns 211 shares of the company’s stock valued at $26,000 after purchasing an additional 132 shares in the last quarter. Root Financial Partners LLC boosted its position in shares of Builders FirstSource by 43.6% during the first quarter. Root Financial Partners LLC now owns 372 shares of the company’s stock valued at $31,000 after purchasing an additional 113 shares in the last quarter. Transamerica Financial Advisors LLC grew its stake in Builders FirstSource by 90.2% in the fourth quarter. Transamerica Financial Advisors LLC now owns 369 shares of the company’s stock worth $38,000 after purchasing an additional 175 shares during the period. Finally, CYBER HORNET ETFs LLC purchased a new stake in Builders FirstSource in the second quarter worth $38,000. 95.53% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth Several equities analysts have commented on BLDR shares. Jefferies Financial Group lowered their price objective on Builders FirstSource from $85.00 to $80.00 and set a “hold” rating for the company in a research report on Monday, May 4th. Benchmark reduced their target price on shares of Builders FirstSource from $105.00 to $100.00 and set a “buy” rating on the stock in a research report on Thursday. Truist Financial decreased their price target on shares of Builders FirstSource from $145.00 to $115.00 and set a “buy” rating for the company in a research note on Thursday, April 30th. Bank of America lowered their price target on shares of Builders FirstSource from $123.00 to $100.00 and set a “neutral” rating for the company in a research report on Monday, April 20th. Finally, Stifel Nicolaus dropped their price objective on shares of Builders FirstSource from $76.00 to $70.00 and set a “hold” rating on the stock in a research note on Thursday. Nine investment analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $100.35.
View Our Latest Report on Builders FirstSource
Builders FirstSource Price Performance NYSE BLDR opened at $72.89 on Friday. The company has a current ratio of 1.76, a quick ratio of 1.09 and a debt-to-equity ratio of 1.15. Builders FirstSource, Inc. has a 12 month low of $65.10 and a 12 month high of $151.03. The stock has a market cap of $7.84 billion, a price-to-earnings ratio of 27.93, a PEG ratio of 1.68 and a beta of 1.42. The company’s 50 day moving average is $77.11 and its two-hundred day moving average is $91.34.
Builders FirstSource (NYSE:BLDR – Get Free Report) last posted its quarterly earnings results on Thursday, April 30th. The company reported $0.27 earnings per share for the quarter, missing analysts’ consensus estimates of $0.39 by ($0.12). The firm had revenue of $3.29 billion during the quarter, compared to the consensus estimate of $3.17 billion. Builders FirstSource had a return on equity of 14.89% and a net margin of 1.97%.The business’s revenue for the quarter was down 10.1% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.51 earnings per share. As a group, research analysts anticipate that Builders FirstSource, Inc. will post 4.29 earnings per share for the current year.
Builders FirstSource declared that its board has authorized a stock repurchase plan on Thursday, April 30th that permits the company to buyback $500.00 million in shares. This buyback authorization permits the company to buy up to 5.4% of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s board of directors believes its stock is undervalued.
About Builders FirstSource (Free Report)
Builders FirstSource, Inc is a leading supplier of structural and value-added building products and services to professional contractors, homebuilders and remodelers. The company provides a comprehensive range of materials and prefabricated components that support all phases of residential construction, from site development and framing to finishing and installation.
The company’s core offerings include lumber and lumber sheet goods, windows and doors, millwork, roofing and siding, and engineered wood products such as roof and floor trusses.
Recommended Stories Five stocks we like better than Builders FirstSource AMD and Cerbras Create A New Blueprint For Hardware Intel Earnings Reveal Whether the Chip Selloff Created a Buy CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for Builders FirstSource Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Builders FirstSource and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEAnchor Investment Management LLC Has $15.39 Million Position in Amazon.com, Inc. $AMZN
NEXT HEADLINE »Allspring Global Investments Holdings LLC Has $3.86 Million Stock Position in Patrick Industries, Inc. $PATK
Arrowstreet Capital Limited Partnership decreased its holdings in shares of Jabil, Inc. (NYSE:JBL – Free Report) by 46.2% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 848,163 shares of the technology company’s stock after selling 728,145 shares during the quarter. Arrowstreet Capital Limited Partnership owned about 0.80% of Jabil worth $225,298,000 as of its most recent SEC filing.
Several other institutional investors have also recently added to or reduced their stakes in JBL. Greenline Wealth Management LLC acquired a new stake in Jabil in the 4th quarter worth about $28,000. Veracity Capital LLC raised its position in shares of Jabil by 4,144.3% in the 4th quarter. Veracity Capital LLC now owns 3,735 shares of the technology company’s stock worth $31,000 after buying an additional 3,647 shares during the period. Virtus Advisers LLC acquired a new position in Jabil in the fourth quarter valued at $32,000. DV Equities LLC purchased a new stake in shares of Jabil during the 4th quarter worth about $34,000. Finally, Wilkerson Advisory Group LLC acquired a new stake in Jabil during the 4th quarter worth approximately $34,000. 93.39% of the stock is currently owned by institutional investors and hedge funds.
Jabil Stock Down 3.0% Shares of NYSE:JBL opened at $312.28 on Friday. The firm has a market cap of $32.72 billion, a PE ratio of 38.99, a price-to-earnings-growth ratio of 0.96 and a beta of 1.28. The company has a fifty day simple moving average of $352.15 and a 200 day simple moving average of $302.26. The company has a current ratio of 0.98, a quick ratio of 0.66 and a debt-to-equity ratio of 2.17. Jabil, Inc. has a 12-month low of $189.60 and a 12-month high of $428.93.
Jabil (NYSE:JBL – Get Free Report) last announced its quarterly earnings data on Wednesday, June 17th. The technology company reported $3.16 earnings per share for the quarter, topping the consensus estimate of $3.10 by $0.06. The company had revenue of $8.75 billion during the quarter, compared to analyst estimates of $8.61 billion. Jabil had a net margin of 2.57% and a return on equity of 83.93%. The firm’s revenue for the quarter was up 11.8% compared to the same quarter last year. During the same period last year, the business earned $2.55 EPS. Jabil has set its FY 2026 guidance at 12.700-12.700 EPS and its Q4 2026 guidance at 3.800-4.200 EPS. On average, equities research analysts anticipate that Jabil, Inc. will post 11.71 EPS for the current fiscal year.
Jabil Announces Dividend The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 2nd. Shareholders of record on Friday, August 14th will be paid a dividend of $0.08 per share. The ex-dividend date is Friday, August 14th. This represents a $0.32 annualized dividend and a yield of 0.1%. Jabil’s dividend payout ratio is presently 4.00%.
Insider Buying and Selling In related news, SVP Gary K. Schick sold 1,000 shares of the firm’s stock in a transaction on Thursday, April 30th. The stock was sold at an average price of $340.00, for a total transaction of $340,000.00. Following the transaction, the senior vice president directly owned 39,843 shares in the company, valued at $13,546,620. This trade represents a 2.45% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Matthew Crowley sold 94 shares of Jabil stock in a transaction on Monday, July 6th. The stock was sold at an average price of $345.00, for a total transaction of $32,430.00. Following the completion of the transaction, the executive vice president directly owned 57,536 shares of the company’s stock, valued at approximately $19,849,920. This represents a 0.16% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 1.35% of the company’s stock.
Analyst Upgrades and Downgrades Several equities research analysts have issued reports on the stock. JPMorgan Chase & Co. boosted their price objective on shares of Jabil from $395.00 to $450.00 and gave the stock an “overweight” rating in a research note on Thursday, June 18th. UBS Group upped their target price on Jabil from $380.00 to $430.00 and gave the stock a “neutral” rating in a research report on Thursday, June 18th. Barclays increased their target price on Jabil from $304.00 to $426.00 and gave the company an “overweight” rating in a research note on Thursday, June 18th. Wall Street Zen lowered Jabil from a “strong-buy” rating to a “buy” rating in a research report on Saturday, April 11th. Finally, Zacks Research upgraded Jabil from a “hold” rating to a “strong-buy” rating in a report on Thursday, July 2nd. Two research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $453.67.
Read Our Latest Research Report on JBL
Jabil Company Profile (Free Report)
Jabil Inc (NYSE: JBL) is a global manufacturing solutions provider specializing in electronic manufacturing services (EMS) and diversified products across a wide range of industries. The company partners with original equipment manufacturers to deliver design engineering, supply chain management, precision manufacturing, and aftermarket services. Jabil’s expertise spans sectors such as healthcare, automotive, clean technology, telecommunications, consumer electronics, and packaging, enabling it to support both high-volume production and complex, mission-critical applications.
Founded in 1966 by William E.
Featured Stories Five stocks we like better than Jabil AMD and Cerbras Create A New Blueprint For Hardware Intel Earnings Reveal Whether the Chip Selloff Created a Buy CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test Plugging In: How Kinder Morgan Powers Up Profits Want to see what other hedge funds are holding JBL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Jabil, Inc. (NYSE:JBL – Free Report).
Receive News & Ratings for Jabil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jabil and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEArrowstreet Capital Limited Partnership Buys Shares of 5,161,983 Dynatrace, Inc. $DT
NEXT HEADLINE »Arrowstreet Capital Limited Partnership Boosts Stock Holdings in Waste Management, Inc. $WM
Arrowstreet Capital Limited Partnership trimmed its position in shares of Cognizant Technology Solutions Corporation (NASDAQ:CTSH – Free Report) by 3.2% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,782,329 shares of the information technology service provider’s stock after selling 91,945 shares during the quarter. Arrowstreet Capital Limited Partnership owned approximately 0.59% of Cognizant Technology Solutions worth $170,696,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors also recently modified their holdings of the company. JPL Wealth Management LLC acquired a new position in Cognizant Technology Solutions in the third quarter worth $25,000. Lodestone Wealth Management LLC bought a new stake in shares of Cognizant Technology Solutions during the fourth quarter valued at approximately $28,000. Flagship Harbor Advisors LLC bought a new stake in shares of Cognizant Technology Solutions during the fourth quarter valued at approximately $28,000. Physician Wealth Advisors Inc. increased its holdings in shares of Cognizant Technology Solutions by 165.1% in the fourth quarter. Physician Wealth Advisors Inc. now owns 342 shares of the information technology service provider’s stock valued at $28,000 after purchasing an additional 213 shares in the last quarter. Finally, Prosperity Bancshares Inc bought a new position in Cognizant Technology Solutions in the 4th quarter worth approximately $29,000. Institutional investors own 92.44% of the company’s stock.
Cognizant Technology Solutions News Summary Here are the key news stories impacting Cognizant Technology Solutions this week:
Positive Sentiment: Cognizant announced a strategic partnership with Gulf Edge to accelerate enterprise AI adoption in Southeast Asia, including Thailand. The deal highlights CTSH’s push into higher-growth AI services and could support longer-term revenue opportunities. Article Title Positive Sentiment: Investors appear to be buying ahead of Cognizant’s second-quarter earnings report on July 29, leaning on the company’s first-quarter momentum, which included revenue growth, strong bookings, and improved margin guidance. Article Title Positive Sentiment: Wall Street still broadly remains constructive: JPMorgan cut its price target to $55 from $74, but kept an overweight rating, while other recent analyst calls have been positive. That suggests expectations may be reset rather than deteriorating. Article Title Neutral Sentiment: Short-interest data did not show a meaningful change, so there is little evidence that the latest move is being driven by a short squeeze or bearish positioning. Negative Sentiment: The JPMorgan target cut reflects lower near-term upside expectations, and the stock remains well below its prior highs, which may temper enthusiasm if upcoming earnings disappoint. Negative Sentiment: Recent insider selling and mixed institutional ownership trends could be a modest headwind for sentiment, even though these factors do not appear to be the main driver today. Analyst Upgrades and Downgrades A number of research analysts have commented on the company. Morgan Stanley set a $44.00 price objective on Cognizant Technology Solutions and gave the company an “equal weight” rating in a research report on Tuesday, June 23rd. JPMorgan Chase & Co. dropped their target price on Cognizant Technology Solutions from $74.00 to $55.00 and set an “overweight” rating for the company in a research report on Friday. Guggenheim cut their price target on Cognizant Technology Solutions from $85.00 to $80.00 and set a “buy” rating on the stock in a research note on Thursday, April 30th. Wells Fargo & Company lowered their price objective on Cognizant Technology Solutions from $83.00 to $61.00 and set an “overweight” rating for the company in a research report on Friday, July 10th. Finally, Deutsche Bank Aktiengesellschaft set a $55.00 price objective on Cognizant Technology Solutions in a report on Friday, July 10th. Ten equities research analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cognizant Technology Solutions currently has an average rating of “Hold” and an average target price of $62.00.
Get Our Latest Research Report on Cognizant Technology Solutions
Cognizant Technology Solutions Stock Up 5.7% NASDAQ:CTSH opened at $45.45 on Friday. Cognizant Technology Solutions Corporation has a 1 year low of $37.08 and a 1 year high of $87.03. The company has a current ratio of 2.23, a quick ratio of 2.23 and a debt-to-equity ratio of 0.04. The stock has a market cap of $21.54 billion, a price-to-earnings ratio of 9.88, a PEG ratio of 0.94 and a beta of 0.87. The stock has a 50-day moving average price of $47.14 and a two-hundred day moving average price of $59.67.
Cognizant Technology Solutions (NASDAQ:CTSH – Get Free Report) last released its quarterly earnings results on Wednesday, April 29th. The information technology service provider reported $1.40 EPS for the quarter, topping analysts’ consensus estimates of $1.33 by $0.07. Cognizant Technology Solutions had a return on equity of 17.50% and a net margin of 10.41%.The company had revenue of $5.41 billion for the quarter, compared to analyst estimates of $5.41 billion. During the same quarter last year, the firm posted $1.23 earnings per share. Cognizant Technology Solutions’s revenue was up 5.8% compared to the same quarter last year. Cognizant Technology Solutions has set its FY 2026 guidance at 5.630-5.770 EPS. As a group, equities analysts expect that Cognizant Technology Solutions Corporation will post 5.7 earnings per share for the current year.
Cognizant Technology Solutions Dividend Announcement The business also recently declared a quarterly dividend, which was paid on Wednesday, May 27th. Shareholders of record on Monday, May 18th were paid a $0.33 dividend. The ex-dividend date of this dividend was Monday, May 18th. This represents a $1.32 dividend on an annualized basis and a yield of 2.9%. Cognizant Technology Solutions’s payout ratio is presently 28.70%.
Cognizant Technology Solutions declared that its Board of Directors has authorized a share buyback program on Monday, May 18th that authorizes the company to repurchase $2.00 billion in shares. This repurchase authorization authorizes the information technology service provider to purchase up to 9% of its shares through open market purchases. Shares repurchase programs are often an indication that the company’s management believes its shares are undervalued.
Cognizant Technology Solutions (NASDAQ: CTSH) is a global professional services company that provides information technology, consulting and business process services to large enterprises. Its core offerings include digital engineering, application development and maintenance, cloud migration and managed services, data analytics and artificial intelligence, cybersecurity, and industry-specific solutions. Cognizant works with clients to design and implement technology-enabled transformations that address customer experience, operational efficiency and new product and service delivery.
Founded in the 1990s and headquartered in Teaneck, New Jersey, Cognizant has grown into a multinational organization with delivery centers and operations across the Americas, Europe, and Asia.
Further Reading Five stocks we like better than Cognizant Technology Solutions AMD and Cerbras Create A New Blueprint For Hardware Intel Earnings Reveal Whether the Chip Selloff Created a Buy CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for Cognizant Technology Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognizant Technology Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEPromising Infrastructure Stocks To Watch Now – July 23rd
NEXT HEADLINE »Southwest Airlines (NYSE:LUV) Price Target Raised to $60.00 at BMO Capital Markets
Bollard Group LLC purchased a new stake in shares of CarGurus, Inc. (NASDAQ:CARG – Free Report) during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 28,525 shares of the company’s stock, valued at approximately $971,000.
A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Horizon Investments LLC boosted its position in CarGurus by 2.0% in the 4th quarter. Horizon Investments LLC now owns 16,375 shares of the company’s stock worth $628,000 after purchasing an additional 318 shares in the last quarter. ProShare Advisors LLC boosted its holdings in CarGurus by 2.8% in the 4th quarter. ProShare Advisors LLC now owns 15,992 shares of the company’s stock worth $613,000 after buying an additional 436 shares during the last quarter. Ritholtz Wealth Management boosted its stake in CarGurus by 4.2% during the 1st quarter. Ritholtz Wealth Management now owns 11,039 shares of the company’s stock worth $376,000 after purchasing an additional 449 shares during the last quarter. HighTower Advisors LLC raised its holdings in CarGurus by 7.8% in the 4th quarter. HighTower Advisors LLC now owns 7,094 shares of the company’s stock valued at $272,000 after acquiring an additional 514 shares during the last quarter. Finally, Illinois Municipal Retirement Fund increased its stake in shares of CarGurus by 1.6% in the 4th quarter. Illinois Municipal Retirement Fund now owns 43,583 shares of the company’s stock worth $1,671,000 after acquiring an additional 679 shares during the last quarter. Hedge funds and other institutional investors own 86.90% of the company’s stock.
CarGurus Stock Up 1.2% CARG stock opened at $33.37 on Friday. The stock has a market capitalization of $3.01 billion, a price-to-earnings ratio of 21.95, a price-to-earnings-growth ratio of 1.20 and a beta of 1.18. The stock’s fifty day simple moving average is $31.24 and its 200-day simple moving average is $32.68. CarGurus, Inc. has a 52-week low of $26.39 and a 52-week high of $39.42.
CarGurus (NASDAQ:CARG – Get Free Report) last issued its earnings results on Thursday, May 7th. The company reported $0.58 earnings per share for the quarter, topping the consensus estimate of $0.56 by $0.02. The business had revenue of $243.56 million for the quarter, compared to analyst estimates of $243.10 million. CarGurus had a return on equity of 54.42% and a net margin of 15.57%.The business’s quarterly revenue was up 8.2% on a year-over-year basis. During the same period last year, the company posted $0.46 EPS. CarGurus has set its Q2 2026 guidance at 0.570-0.640 EPS. As a group, analysts anticipate that CarGurus, Inc. will post 2.11 earnings per share for the current fiscal year.
Insider Buying and Selling at CarGurus In other news, General Counsel Javier Zamora sold 3,533 shares of the stock in a transaction on Thursday, July 2nd. The stock was sold at an average price of $36.06, for a total value of $127,399.98. Following the completion of the transaction, the general counsel owned 88,345 shares of the company’s stock, valued at approximately $3,185,720.70. This represents a 3.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CTO Matthew Todd Quinn sold 3,824 shares of the firm’s stock in a transaction that occurred on Thursday, July 2nd. The stock was sold at an average price of $35.03, for a total transaction of $133,954.72. Following the sale, the chief technology officer owned 233,146 shares of the company’s stock, valued at $8,167,104.38. The trade was a 1.61% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 25,559 shares of company stock worth $841,568. 18.19% of the stock is owned by insiders.
Analyst Ratings Changes Several research firms recently weighed in on CARG. Citigroup began coverage on shares of CarGurus in a report on Friday, June 12th. They issued a “buy” rating for the company. Wall Street Zen upgraded shares of CarGurus from a “hold” rating to a “buy” rating in a report on Saturday, June 27th. Piper Sandler reiterated a “sector weight” rating on shares of CarGurus in a research note on Friday, June 12th. Weiss Ratings downgraded CarGurus from a “hold (c+)” rating to a “hold (c)” rating in a report on Wednesday, May 13th. Finally, Barclays raised their price objective on shares of CarGurus from $35.00 to $40.00 and gave the stock an “overweight” rating in a report on Tuesday. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $38.55.
View Our Latest Stock Analysis on CARG
CarGurus Company Profile (Free Report)
CarGurus, Inc operates an online automotive marketplace designed to connect buyers and sellers of new and used vehicles. Through its proprietary search engine and data-driven pricing tools, the platform enables consumers to compare listings, assess fair market values and locate local dealers offering competitive deals. CarGurus also provides detailed vehicle history reports, dealer reviews and financing options to streamline the car-shopping process for both private parties and franchised dealerships.
The company’s core product offerings include Instant Market Value (IMV), which leverages pricing algorithms to help buyers identify over- or under-priced vehicles, as well as dealer subscription services that grant automotive retailers access to lead generation tools, targeted advertising and dynamic pricing insights.
Featured Stories Five stocks we like better than CarGurus AMD and Cerbras Create A New Blueprint For Hardware Intel Earnings Reveal Whether the Chip Selloff Created a Buy CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test Plugging In: How Kinder Morgan Powers Up Profits Want to see what other hedge funds are holding CARG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CarGurus, Inc. (NASDAQ:CARG – Free Report).
Receive News & Ratings for CarGurus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CarGurus and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEBollard Group LLC Has $16.83 Million Stock Holdings in CocaCola Company (The) $KO
NEXT HEADLINE »Aristotle Capital Management LLC Sells 3,338 Shares of Aercap Holdings N.V. $AER
Not financial or tax advice. PANews content is strictly educational and informational and is not investment advice, financial advice, tax advice, legal advice, or a solicitation to buy or sell any digital asset, security, or financial product. Do your own research and consult qualified advisers.
Disclosure. PANews may publish sponsored content, partner content, advertisements, affiliate links, event promotions, and market commentary involving Web3 projects, service providers, or financial products. PANews personnel, contributors, or affiliates may hold digital assets or other interests related to covered topics. See our Terms of Service.
SummaryAxon Enterprise delivered strong Q1 results, raising full-year topline growth guidance to 30-32% with a robust $14.3 billion backlog.Despite resilient adjusted EBITDA margins (~25%), free cash flow (FCF) margins have deteriorated, pulling the Rule of 40 (cash-based) below 40 for 2025.Structural cash conversion issues, driven by multi-year contracts and increased receivables, offset the compelling growth and moderate valuations.I maintain a Hold rating, prioritizing improvement in FCF generation and the receivables-to-unearned revenue ratio before considering a Buy. sommart/iStock via Getty Images
Axon Enterprise (AXON) reported a strong Q1 and the outlook on growth continues to be supportive and well visible. Revenue grew ~34% YoY, and the full-year guidance was raised to 30-32% topline growth. The contracted bookings backlog is ~$14.3b (4-5x TTM
4.76K Followers
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Wingstop (WING +0.25%) will report its second-quarter results before the market opens on July 29. The stock has been cut almost in half so far this year, which has some investors wondering whether they should buy ahead of the report. I think that is the wrong way to frame the question. The better way to think about it is to ask how this quarter will fit Wingstop's long-term story.
The pressure point for the chain is same-store sales. After more than two decades of growth, Wingstop's comparable sales numbers have been shrinking. Domestic comps fell by a percentage in the high single digits last quarter. Management expects a low-single-digit decline for the full year. So the question investors will want the answer to is simple: Is the slide stabilizing?
Image source: Getty Images.
Also, watch what it's doing to fix the problem. Wingstop is pushing value deals under $10, rolling out its Smart Kitchen technology, and leaning on delivery and loyalty. Any signs that these steps are drawing more customer traffic back into its restaurants would matter.
Today's Change
(
0.25
%) $
0.34
Current Price
$
135.20
The thesis is bigger than one quarter All that said, I would not fixate on comps, and here's why. Wingstop's real engine for growth is new stores. The company still expects 15% to 16% global unit growth this year, and franchisees are opening locations quickly. Systemwide sales keep rising even as comps dip. Digital orders now make up more than 72% of sales, which gives the company data and efficiency that few rivals can match.
The unit economics are the draw. New Wingstop restaurants are cheap to build and generate strong returns. That's why franchisees keep signing up. A soft quarter or two will barely dent a runway that stretches toward thousands of new stores over the coming years. Long-term value comes from opening more high-return restaurants, not from any single quarter's comps figure.
The takeaway for investors So, should you buy Wingstop before July 29? Trying to trade on one earnings report is closer to gambling than investing, so I would not rush in just to beat the date. But the investment thesis for the company is intact. If you believe it can deliver years of rapid unit growth, deep digital penetration, and excellent store economics, then the stock, after a decline that has brought it down to less than a third of its 2024 peak price, looks like an opportunity.
Wingstop is far from alone here. Peers such as Chipotle Mexican Grill and Cava are running the same playbook, expanding aggressively while prizing unit economics over quarterly comps.
But if you buy Wingstop stock, do it because you want to own a fast-growing restaurant franchise for the next decade. Do not buy it because you are betting on Wednesday's headline. Let the long-term story decide, and treat the quarter as one data point along the way. If the comp slide is stabilizing, all the better. If not, patient investors who trust the company's expansion engine have little reason to panic over a single print.
Micah Zimmerman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Cava Group and Chipotle Mexican Grill. The Motley Fool recommends Wingstop and recommends the following options: short September 2026 $35 calls on Chipotle Mexican Grill. The Motley Fool has a disclosure policy.
SummarySoFi is aggressively seeking to diversify its lending focused revenue stream with new product expansions via an AI investment platform, stablecoins, financial planning and investment products. Q1 debit spending rebounded, particularly in travel and dining, but tax refunds appear to have driven the increase. Meanwhile, consumer sentiment remains very weak at multi-decadal lows. Investors should focus on Q2 revenue guidance, as SoFi has regularly beaten reported-revenue estimates while guidance has been less compelling. SoFi’s valuation implies nearly 41% 5-yr earnings CAGR growth, above the 35% consensus forecast. Technicals are mixed: bearish momentum persists, but the stock is holding a key resistance-turned-support level. Joe Hendrickson/iStock Editorial via Getty Images
Performance assessment SoFi Technologies (SOFI) has gone mostly sideways since my last update. It has beaten the market by >6%, but I do not view that as very material as that kind of
8.84K Followers
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
SoFi Technologies is rated 'Strong Buy' with a $22–$26 fair value, reflecting a significant discount to peers despite robust book value growth. SOFI's tech-enabled banking model drives high product-per-member growth and fee diversification, with 43% of new products in Q1 coming from existing members. The company trades at 2x book value versus JPMorgan's 2.62x and Nu Holdings' 5x, yet boasts superior credit quality and a simpler, lower-risk balance sheet.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in JOBY over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
The information contained herein is for informational purposes only. Nothing in this article should be taken as a solicitation to purchase or sell securities. Before buying or selling any stock, you should do your own research and reach your own conclusion or consult a financial advisor. Investing includes risks, including loss of principal.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
SummaryGladstone Land faces rising OpEx, dividend coverage issues, and tenant concentration risks, prompting a revised 'Hold' rating.LAND’s shift to crop-share agreements increased exposure to farm trends and seasonality, further pressuring AFFO and dividend sustainability.I see a necessary dividend reset to $0.30/share and a $6/share price target, reflecting required deleveraging and cost control.Current valuation and risk profile do not justify entry; I await meaningful financial improvements or a lower share price.Looking for more investing ideas like this one? Get them exclusively at Wolf of Value. Learn More » BJP7images/iStock Editorial via Getty Images
A few years ago, I was a lot more "into" and interested in REITs than I am today. The business model and the corresponding yields were very appealing to me when I built a more income-centric investment portfolio. However, around
35.34K Followers
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
While this article may sound like financial advice, please observe that the author is not a CFA or in any way licensed to give financial advice. It may be structured as such, but it is not financial advice. Investors are required and expected to do their own due diligence and research prior to any investment. Short-term trading, options trading/investment and futures trading are potentially extremely risky investment styles. They generally are not appropriate for someone with limited capital, limited investment experience, or a lack of understanding for the necessary risk tolerance involved. I own the European/Scandinavian tickers (not the ADRs) of all European/Scandinavian companies listed in my articles. I own the Canadian tickers of all Canadian stocks I write about. Please note that investing in European/Non-US stocks comes with withholding tax risks specific to the company's domicile as well as your personal situation. Investors should always consult a tax professional as to the overall impact of dividend withholding taxes and ways to mitigate these.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
NextEra Energy (NYSE:NEE | NEE Price Prediction) and Brookfield Renewable Partners (NYSE:BEP) both posted Q1 2026 results that sharpen a long-running income debate.
NextEra leaned on its Florida utility and a swelling renewables backlog. Brookfield leaned on hydro cash flow and a Westinghouse-driven nuclear push, while a derivatives mark dragged GAAP earnings. For dividend investors, the two now offer very different flavors of the same clean-power thesis.
Florida Utility Cash vs. Global Hydro Cash NextEra’s Q1 was clean. Adjusted EPS came in at $1.09, up 10% YoY, on revenue of $6.70B. Florida Power & Light added roughly 100,000 customers and brought about 600 MW of new solar online, while NextEra Energy Resources booked a record origination quarter with 4 GW added to a backlog now near 33 GW.
CEO John Ketchum told investors NextEra expects “to grow adjusted earnings per share at a compound annual growth rate of 8%+ through 2032″. That is the kind of visibility income buyers pay up for.
Brookfield’s quarter looked messier on the surface. GAAP net loss hit $295M, weighed by a $193M mark-to-market hit on long-term power derivatives. Underneath, proportionate FFO reached $375M, or $0.55 per unit, up 19% YoY, and the business commissioned roughly 1,800 MW of new capacity.
Connor Teskey framed the tone plainly, citing “the multi-decade trends of reindustrialization and electrification” amplified by data centers. Hydroelectric alone contributed $712M in revenue, the closest thing in renewables to a utility annuity.
The Dividend Math Is Not Close Dividend Lens NEE BEP Quarterly payout $0.6232 $0.392 Indicated yield 2.64% 4.89% Growth target ~10% through 2026, then 6% through 2028 5% to 9% annually Structure C-corp, 1099 LP, K-1 Brookfield pays you more today. NextEra grows the check faster and does not saddle you with a K-1. The current quarterly step from $0.5665 in 2025 to $0.6232 in 2026 shows NextEra still walking that 10% path.
The same investor newsletter that told subscribers to buy Amazon in 2002, Netflix in 2004, and Nvidia in 2005 still publishes two new stock picks every month. Over 23 years, Motley Fool's Stock Advisor has more than quadrupled the S&P 500. New members get this month's picks, the Top 10 Rankings, and a 30-day money-back guarantee. Click here to unlock their next top stocks while new members are still being accepted.
Brookfield moved from $0.373 to $0.392, a solid mid-single-digit bump backed by a 12-year weighted-average contract duration and 92% contracted revenue for the rest of 2026.
What I Am Watching Into 2027 For NextEra, I want to see the 9.5 GW of new gas-fired generation tied to the U.S.-Japan trade deal move from press release to concrete, and the Duane Arnold nuclear restart deliver its expected $0.16 in annual adjusted EPS.
For Brookfield, the Boralex acquisition, the 3,000 MW Google hydro framework, and Westinghouse’s AP1000 push will determine whether that 12% to 15% long-term total return target holds. Rising corporate borrowings, now $4.8B versus $3.7B, deserve attention too.
Why I Lean NEE for Sleep-at-Night Income If I am building a core dividend position and I want to stop thinking about it, I take NextEra. The regulated FPL earnings base, a beta of 0.667, and a clear 8%-plus EPS runway through 2032 give me a rare mix of yield growth and stability. The 18.64% one-year return is a welcome tailwind on top of the thesis.
If I already own steady utilities and I want a higher current payout with more upside variance, Brookfield fits, especially given its 22.14% YTD move and Westinghouse optionality. I would not own it in a taxable account without accepting the K-1 friction. For most income investors I talk to, NextEra remains the cleaner dividend stock today.
If You'd Bought Amazon When the Motley Fool Said To…In September 2002, Stock Advisor told subscribers to buy Amazon. In December 2004, Netflix. In April 2005, Nvidia. The newsletter still publishes two new stock picks every month — and over 23 years, has more than quadrupled the S&P 500. Here's how to get this month's picks:
- Join Stock Advisor for one year, with a 30-day money-back guarantee
- Get this month's two new picks — plus the Top 10 Rankings and the full historical pick list
- Read the analysis, decide for yourself, and trade through your own brokerage
Five years from now, you'll probably wish you'd bought this month's picks. Don't miss them.
On Thursday, nuclear start-up Oklo (OKLO -8.43%) announced some welcome news. The company received “startup authorization” from the U.S. Department of Energy (DoE) for its Groves Reactor in Texas under the Reactor Pilot Program (RPP).
According to the company, the authorization “allows Oklo to load nuclear fuel, conduct startup testing, and proceed toward first criticality.”
It’s a big step forward for Oklo and one that is likely to have a major impact on the company’s regulatory future. Here’s what this authorization means for Oklo and why it’s a bigger deal than it seems for Oklo investors.
Image source: The Motley Fool.
Slower than molassesIn the world of nuclear regulations, safety is the biggest priority. That makes sense given the massive destructive potential of even a small nuclear reactor. Speed, on the other hand, isn’t a priority.
If anything, that’s an understatement. Obtaining commercial certification from the U.S. Nuclear Regulatory Commission (NRC) for a new reactor design takes years or even decades.
Oklo knows this better than anyone: the company began the regulatory journey for its novel sodium-cooled fast reactor SMR with the NRC in November 2016, almost ten years ago. It finally was able to submit its combined license application for the Aurora Powerhouse design in March 2020. And it’s still anybody’s guess when it might be awarded a commercial license.
The company has completed three of the five steps of its DoE RPP regulatory review for construction and operation, while an NRC audit is in progress. Once the audit is completed, the company can formally request a commercial license. It will undergo further NRC review before receiving approval... assuming neither the audit nor the review turns up any material issues that need to be corrected.
A breakneck paceThis painfully slow process is one of the reasons the U.S. hasn’t begun construction of a new nuclear power plant since 1976, and why only two existing plants have added new reactors since 1993.
The Trump Administration aimed to change that with the RPP, which was enacted by executive order in 2025 to speed up the deployment of nuclear reactors in the U.S. The RPP instructs the NRC to create an expedited pathway to approve reactors that have been safely tested by the DoE, with a deadline of 18 months to evaluate and approve new construction and operation licenses.
The RPP allowed the Groves Reactor project to move forward at unprecedented speed. The time from groundbreaking to receiving start-up authorization was just over 10 months, which included construction, hiring, fuel and equipment procurement, and the DoE authorization process.
Today's Change
(
-8.43
%) $
-3.71
Current Price
$
40.29
Even Oklo CEO Jacob DeWitte seemed surprised by the breakneck pace. "This facility marks the fastest time that we are aware of to go from greenfield to substantial completion for a full-scale, privately funded and sited reactor in history,” he said in a press release.
But the important part was what he said next: “And this experience is fully translatable to future commercial deployments.” Here’s why that should be music to shareholders’ ears.
The hidden benefitThe Groves Reactor isn’t a nuclear power plant, nor does it feature Oklo’s unique sodium-cooled fast reactor SMRs. It’s a water-cooled test reactor designed to use low-enriched uranium for the production of isotopes, like those used in radiation therapy for cancer.
Currently, most radioactive isotopes used in the U.S. are produced overseas. The Groves Reactor is part of an effort to increase domestic production.
But Oklo’s primary goal is to build SMRs for power generation. The Aurora Powerhouse uses a different reactor design and fuel, and serves a different purpose. So, how does this move Oklo towards that goal?
Well, in the world of nuclear authorizations, repeating yourself is a good thing. Through the RPP, certain portions of DoE approval are expected to directly transfer to the NRC approval process, expediting the review time frame.
Image source: Getty Images.
The takeawayBecause Groves is a commercial-scale facility, Oklo notes it can “repeat the experience with demonstrated experience in siting, building, commissioning, and operating its commercial reactors in the future.”
The company also believes that the “repeatable approach to engineering, construction, commissioning, operations, and regulatory authorization ... helps reduce execution risk and accelerate future deployments across all of Oklo’s business units.”
If the process for the Aurora Powerhouse moves forward as quickly as the Groves process, Oklo could find itself months or even years ahead of schedule on its ultimate plan.
Down 15% from June's initial public offering price and more than 30% below its post-IPO peak, it's safe to say many investors are more than a little disappointed in Space Exploration Technologies' (SPCX -2.85%) -- you know it better as SpaceX -- shares so far.
So now what? Is it worth buying or continuing to hold at its current price? Or, should investors take the recent weakness at face value and throw in towel on this ticker?
Maybe something in between.
History says With the dust of this mid-June IPO finally settling, it's time to say out loud what most people have only been quietly thinking to themselves. That is, like almost all other major initial public offerings for the past three decades, this one was buoyed by hype that was never built to last.
Today's Change
(
-2.85
%) $
-3.37
Current Price
$
114.87
The stock could continue sinking before finding a bottom, too. Brokerage firm Edward Jones reports that between 2011 and 2020 -- a period when then-Facebook Meta, Peloton, Snapchat parent Snap, and Twitter (now X) all went public -- the average newly minted technology stock was down 14% from its IPO price just six months following its public offering. Again, IPO hype has an all-too-familiar pattern. Never mind the end of the lockups keeping current SPCX shareholders from shedding their now-deteriorating positions, which, of course, would only add to the selling pressure.
Longer-term, still a long shot Just don't feel like you necessarily need to forego a stake in SpaceX forever. Post-IPO performance numbers from Nasdaq Economic Research indicate that between 2010 and 2020, newly public companies generating annual revenue in excess of $100 million end up, on average, at least keeping pace with the broad market's gains, if not slightly beating them.
Image source: Getty Images.
Still, take that information with a grain of salt. While the average three-year performance is positive, this average is skewed by a small handful of overperformers. Nearly two-thirds of these stocks were still in the red three years after their IPO.
In other words, don't bet the farm if you decide to go bottom-fishing.
James Brumley has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Meta Platforms and Peloton Interactive. The Motley Fool has a disclosure policy.
After weeks of waiting, investment management firm Vanguard finally updated the holdings of its 48 passively managed equity exchange-traded funds (ETFs).
Unsurprisingly, Space Exploration Technologies (SPCX -2.85%) popped up in the Vanguard Total Stock Market ETF, the Vanguard Growth ETF, and the Vanguard Mega Cap Growth ETF, among others.
By far the biggest surprise was that, as of June 30, SpaceX is the No. 1 holding in the Vanguard Extended Market ETF (VXF -0.28%), ahead of 3,371 other stocks.
This is no small ETF by any means -- the Vanguard Extended Market ETF has $97.7 billion in net assets and traces its inception date back to December 2001.
Here's why SpaceX is now the top holding of the Vanguard Extended Market ETF and how it compares to the other Vanguard ETFs that bought SpaceX in June.
Image source: Getty Images.
SpaceX is making waves in the ETF world The Vanguard Extended Market ETF's 6,775,494 shares of SpaceX were valued at $1.158 billion as of June 30. The fund includes a blend of small- and mid-cap stocks, with a few large caps sprinkled in. So you may be wondering why a stock like SpaceX is in the ETF, given it has a $1.63 trillion market cap and is one of the 10 largest U.S. companies by market cap.
SpaceX's initial public offering was the largest in history based on SpaceX's valuation. But SpaceX raised just $75 billion by selling 555 million shares at $135 each and another $10.7 billion from underwriters with options to buy additional shares -- far less than its valuation. So the number of shares available for public trading on the Nasdaq -- known as the float -- is only around 5% of SpaceX's total shares outstanding.
Because SpaceX's float is such a small percentage of its market cap, the rules-based S&P 500 Completion Index that the Vanguard Extended Market ETF is modeled after probably classified SpaceX as something other than a megacap stock. This is why SpaceX was pole-vaulted to the fund's top holding in a matter of weeks.
These same market dynamics are why SpaceX makes up such a small percentage of funds like the Vanguard Growth ETF. If SpaceX were weighted by market cap, it would have a weighting similar to Meta Platforms at about 3.4%. Instead, SpaceX is just 0.29% of the fund, weighted by a multiple of its float rather than market cap.
NYSEMKT: VXFVanguard Index Funds - Vanguard Extended Market ETF
Today's Change
(
-0.28
%) $
-0.66
Current Price
$
236.13
The IPO wild west is just beginning Float-based market cap weightings are effective because they act as a check-and-balance system on ETF demand. If SpaceX were weighted by market cap, then ETFs would artificially drive up its price, given how few of its outstanding shares are available for trading on the Nasdaq. But the pattern in which passively managed Vanguard ETFs are buying SpaceX showcases the imperfect system of megacap IPOs.
As SpaceX gradually unlocks shares starting Aug. 6, investors can expect it to make up a larger share of well-known ETFs like the Vanguard Growth ETF and Vanguard Total Stock Market ETF. But that larger float will also likely trigger SpaceX's removal from the Vanguard Extended Market ETF.
How ETFs are responding to SpaceX is a reminder to always understand what you're buying and why you're holding it. In the case of the Vanguard Extended Market ETF, I wouldn't be surprised if it dumped its entire SpaceX holding before the end of the year, but also had a short period where upcoming megacap IPOs like Anthropic and OpenAI would become top holdings, only to eventually be removed from the ETF.
HomeIndustriesTelecommunicationsTelecom StocksTelecom StocksIt would likely be too expensive and time-consuming for SpaceX to build a mobile network on its own. But the major wireless carriers have to hope one of their rivals doesn’t sell out.July 25, 2026, 8:00 a.m. ET
Ever since T-Mobile and Sprint merged in 2020, the U.S. wireless-communications market has operated as a comfortable oligopoly. But lately, investors have worried that Elon Musk’s SpaceX plans to disrupt what’s been a predictable market for telecommunications services.
SpaceX’s SPCX Starlink business has so far been a niche provider to rural areas. But the company’s initial-public-offering prospectus in May revealed that Starlink Mobile has ambitions to massively penetrate suburban and urban markets too — with the goal of providing better connectivity than what can be offered by cell towers on the ground.
SpaceX (NASDAQ: SPCX) could decline to $50 per share between August 2026 and the first half of 2027 if a series of bearish catalysts align, according to ChatGPT.
Notably, the AI model does not consider a drop to $50 the most likely outcome. However, it believes the risk becomes more significant if insider selling accelerates after lockup restrictions are lifted, earnings disappoint, and progress on Starship remains delayed.
The assessment comes after SpaceX stock fell about 50% from its post-IPO high above $225 to trade around $115 as of press time.
SpaceX 30-day stock price chart. Source: Finbold ChatGPT identified August through October 2026 as the period most likely to trigger another major decline.
The company is scheduled to report second-quarter earnings on August 4, while more than 911 million previously restricted shares are expected to become eligible for sale shortly afterward.
A combination of weaker-than-expected financial results and heavy insider selling could increase downward pressure on the stock as the market adjusts to a significantly larger share float. Additional lockup expirations expected in 2027 could create a second period of elevated volatility.
Odds of SpaceX stock dropping to $50 Despite these risks, ChatGPT believes SpaceX’s business fundamentals reduce the probability of a collapse to $50.
In this line, Starlink has become the company’s primary earnings engine, generating approximately $3.26 billion in quarterly revenue and about $1.19 billion in operating income. Meanwhile, SpaceX continues to dominate commercial launch services and is expanding its presence in government and defense contracts.
The company generated roughly $18.7 billion in revenue during 2025, representing annual growth of about 33%.
Based on current fundamentals, ChatGPT views a trading range of $90 to $130 as the most likely outcome over the coming months, assigning a 45% probability to that scenario.
The model estimates a 30% chance of the stock falling to between $70 and $90 and a 15% probability of a decline into the $50 to $70 range. The likelihood of SpaceX falling below $50 is estimated at 10%.
SpaceX stock price prediction. Source: ChatGPT SpaceX stock sell-off explained Meanwhile, the recent selloff has been driven largely by concerns over valuation and increasing share supply rather than weakening business performance.
Following its June IPO at $135, SpaceX surged above $225 as investors piled into one of the market’s most anticipated listings. Sentiment later shifted as attention turned to upcoming lockup expirations and the company’s premium valuation.
Starship delays have also weighed on the stock, as the program remains central to SpaceX’s long-term growth strategy.
Best Crypto Exchange for Intermediate Traders and Investors
Invest in cryptocurrencies and 3,000+ other assets including stocks and precious metals.
0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.
Copy top-performing traders in real time, automatically.
eToro USA is registered with FINRA for securities trading.
30+ million Users worldwide
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk. Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you should not expect to be protected if something goes wrong. Take 2 mins to learn more.
Join Finbold's newsroom, become a Sales Executive today! Apply now to join Finbold as a crypto/finance news writer!
Apple's total revenue expected for fiscal Q3 has ticked up since late January but is flat at $108.1 billion from last quarter, according to Visible Alpha consensus. Expectations for the high-margin Services segment remained stable for Q3 at $31.4 billion. Apple stock has been up 11.3% since May and 26.3% since January 2026.
SummaryI previously called the SpaceX optionality, and that call was dead wrong. The business underneath it got worse, so I'm downgrading to a sell.Texas registrations quadrupled in six weeks. Cars actually driving unsupervised: still about twenty. Registered isn't driving, and I need unsupervised autonomous driving.Strip out the SpaceX mark and the tax benefit, and roughly $77 million of profit is left on $28.2 billion of revenue. A 1.4% operating margin is the real quarter.I'm watching two things into late October: does the driverless fleet finally grow, and does SPCX bounce back? If they do, this downgrade ages badly. hirun/iStock via Getty Images
Two-thirds of Tesla's (TSLA) reported profit this quarter traces back to a stock Elon Musk's other company just took public.
Equity gains, or should I say “gainz” to sound a bit cooler, because there are quite a few tech
14.12K Followers
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
I am not a registered investment adviser, broker, dealer, or tax professional. This article, including any comments or replies I post, reflects my personal opinions only and is provided for informational and educational purposes. Nothing I write is investment, legal, tax, or financial advice, or a personalized recommendation to buy, sell, hold, or short any security. My views may change without notice. Nothing I write is tailored to any reader’s objectives, financial situation, risk tolerance, or portfolio. Investing involves risk, including possible loss of principal. Readers should conduct their own research and consult a qualified professional before making investment decisions.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Coca-Cola (NYSE:KO | KO Price Prediction) offers retirement investors a rare combination of reliable income and accelerating growth ahead of its upcoming Q2 earnings report on July 28. The company just raised its dividend for the 64th consecutive year, expanded its operating margin from 32.9% to 35.0%, and raised 2026 EPS guidance from 8% to 9%. Coca-Cola may trade like a sleepy consumer staple, but its latest results show a Dividend King gaining momentum.
Three Reasons the Buy Case Writes Itself The cash machine is accelerating. Q1 2026 delivered $12.47B in revenue, up 12.07% year over year, on 10% organic growth and EPS of $0.86 that beat estimates by 5.87%, the fourth consecutive EPS beat. Free cash flow climbed 131.85% year over year to $1.755B, and management guided to roughly $12.2B of free cash flow for 2026. That covers the $8.8B in dividends paid in 2025 with meaningful room to spare.
Dividend income is durable and growing. Coca-Cola’s quarterly payout rose from $0.51 to $0.53 in 2026, giving a 2.51% dividend yield layered on top of a 45.97% return on equity. Coca-Cola raised the dividend through 2008, 2020, and every macro shock in between.
Management is prioritizing share buybacks too. KO repurchased $477M in Q1 2026 with roughly $5.2B still authorized. Shares are already up 17.67% year to date and 20.71% over one year.
Why Coca-Cola Deserves to Trade at a Premium Coca-Cola’s classic competitor is PepsiCo (NASDAQ:PEP), which offers a fatter 4.24% dividend yield at a cheaper 18 P/E. While Pepsi may look optically cheaper, PepsiCo’s quarterly revenue growth of 6.4% is roughly half of Coca-Cola’s 12.1%, and its 16.8% operating margin is a fraction of KO’s 35.0%.
Keurig Dr Pepper (NASDAQ:KDP) is worse on quality, with the company reporting a 6.31% ROE and quarterly earnings growth of -47.7%. Investors pay a premium for KO because KO is a better business.
KO’s One Weak Spot The bear case for Coca-Cola revolves around input-cost pressure and a 17% decline in Asia Pacific operating income. However, consolidated operating margin still expanded 210 basis points, and North America, EMEA, Latin America, and Bottling Investments all posted double-digit revenue growth in Q1 2026. For retirement portfolios needing rising income backed by a fortress balance sheet, Coca-Cola may be worth a closer look ahead of July 28 Q2 earnings.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Coca-Cola didn't make the cut. Grab the names FREE today.
Although Warren Buffett no longer heads Berkshire Hathaway, its stock trades and positions continue to attract plenty of attention. At one time, nearly half of the conglomerate's massive stock portfolio consisted of its stake in Apple (AAPL +3.53%), and though it has sold a large number of shares, the iPhone maker remains its largest equity position.
More recently, Berkshire has been adding to its position in Google parent Alphabet (GOOGL +0.58%) (GOOG +0.21%), even as the conglomerate continues to increase its liquidity by selling other companies' shares. Still, that position remains much smaller than its Apple holdings, and Buffett has publicly said he sold Apple "too soon." Despite that admission, Alphabet is likely the better buy among these two "Magnificent Seven" stocks right now, and here's why.
Image source: The Motley Fool.
Comparing Apple and Alphabet Apple now makes up around 21% of Berkshire's portfolio, significantly above the approximately 8% of the portfolio it now has invested in Alphabet.
Moreover, investors have plenty of reasons to like Apple. For one, it has outperformed Alphabet so far in 2026 as a device upgrade cycle, particularly with the iPhone, has helped accelerate its revenue growth.
AAPL data by YCharts.
Nonetheless, Alphabet has delivered higher shareholder returns than Apple over the past one-year and five-year periods. Also, Berkshire Hathaway's most obvious indication as to whether it prefers Alphabet or Apple is its recent activity. Over the last year, it sold more than 52 million Apple shares, and that came after selling more than 600 million shares in prior quarters. That took its position down to around 228 million shares.
Today's Change
(
3.53
%) $
11.36
Current Price
$
333.02
In contrast, Berkshire had never traded Alphabet until the third quarter of 2025, when it made its first buy. It purchased more shares in 2026's first quarter, and then announced in June that it had invested $10 billion more in the company in the second quarter via a private placement, buying those shares directly from Alphabet. Analysts now believe it holds more than 86 million Alphabet shares. Buffett later said that he was behind Berkshire's decision to invest in Alphabet.
Furthermore, Alphabet has become the more prominent AI innovator of these two, particularly with the success of Google Gemini and the market leadership of Waymo in the emerging autonomous vehicle market. In contrast, Apple appears to have little interest in getting involved in the AI infrastructure race, and has signed deals to run its next-generation Apple Foundation Models on the Google Cloud platform.
Despite its competitive advantages, Alphabet has offered investors a more attractive valuation in recent months. It trades at 25 times trailing earnings, well below the Apple price-to-earnings ratio (P/E) of 39. And the Google parent's earnings multiple had fallen to as low as 19 in July last year, giving Berkshire all the more reason to begin buying the stock when it did.
Choose Alphabet over Apple As Berkshire Hathaway's recent behavior confirms, Alphabet is likely the better buy right now, although the iPhone's continued strength and its current upgrade cycle give Berkshire a compelling incentive to hold Apple stock.
Today's Change
(
0.21
%) $
0.66
Current Price
$
319.00
However, over the last year, it is also clear that Berkshire expressed its preference by selling Apple shares and buying Alphabet stock. Moreover, the latter trades at a lower P/E despite Apple's decision to use the Google parent's AI platform.
Thus, investors contemplating this question should probably take their cues from Berkshire's actions and choose Alphabet's stock over Apple's.
The market is getting increasingly skeptical about Google's declining free cash flow margins. I think the market is overreacting. I believe Google is investing aggressively in AI from a position of strength, not one of weakness. Google has been able to infuse AI pervasively across its ecosystem, and it is not looking to slow down.
Close-up of a person's hand holding an iPhone and using Google AI Mode, an experimental mode utilizing artificial intelligence and large language models to process Google search queries, Lafayette, California, March 24, 2025. (Photo by Smith Collection/Gado/Getty Images)
Gado via Getty Images
Apple’s Siri AI isn’t very smart. That’s why future iPhones will pair Siri with Google’s highly regarded Gemini AI.
Seemingly what you’ve just read has been glossed over by the European Union (EU). As news accounts the last few days indicate, the EU has fined Google $1 billion for “unfairly” favoring “its own services on its widely used search engine.”
Except that Google’s “widely used search engine” is widely used for many reasons, including that Google’s services are unrivaled. In other words, Google could deemphasize its services only if it wanted to drive users away from its own “widely used search engine.”
This is worth remembering with a deeper look into the EU’s fine top of mind. It’s not so much about Google as it’s about third-party entities that want their products and services more heavily emphasized on Google’s “widely used search engine.”
Ok, but the third parties can’t have it both ways. Neither can EU regulators.
What makes favoring on Google’s “widely used search engine” so desirable for entities outside Google is how popular Google is among individuals the world over. Which means that Google, to remain Google, must continue to not just meet, but lead the needs of users who have myriad choices. This includes prominently featuring its unrivaled products. About this, Apple instructs.
Popular as the iPhone is, Apple has never hidden from Siri’s limitations. It similarly hasn’t hidden from the fact that at least at present, it doesn’t have a ChatGPT, Copilot, Gemini, Grok, or Meta AI equivalent. Has the latter signaled Apple’s decline? Far from it.
MORE FOR YOU
As was argued here in March, and surely without knowing what’s ahead in AI or anything else (how many inside and outside technology predicted the before and after of November 30, 2022?), Apple has positioned itself brilliantly for the potential commoditization of AI. Rather than spend copious sums developing it, Apple opened its iPhones and other devices up to the genius of others. This once again includes Google and its Gemini AI.
Fully cognizant that the utility of its products is quite a bit greater when paired with technological advances achieved outside its own Cupertino walls, Apple is actively opening its “widely used” devices to non-Apple technology. Which is something EU regulators plainly glossed over in foisting the $1 billion fine on Google.
Really, what is Google supposed to do? Do EU regulators seriously expect it to favor the technology of others on its widely used search engine, particularly if what’s produced by others doesn’t measure up to what’s been developed inside Google? EU regulators aren’t just demanding that Google choose a path of self-harm that is anti-consumer, they’re also demanding that it harm itself in such a way that will imperil the commercial development of the very third parties intent on utilizing Google’s popularity as their own growth strategy.
Which requires a look at the accusatory core of the EU’s case and its $1 billion fine of Google. Implied in the latter is that in favoring its own services over those of outside providers, Google has been restraining the development and growth of outside providers. Nothing could be further from the truth. See Apple again.
As evidenced by Apple’s incorporation of Google’s Gemini into its Siri product, no business can remain great by providing a subpar product. Google’s Gemini will immediately make Apple’s products a great deal more appealing in the marketplace, and so will Google’s suite of products and services be much more appealing the better they are, and regardless of where the improvements come from. Fines aren’t the answer to the EU’s laments, but better third parties are.
SummaryAlphabet's FQ2'26 showed negative free cash flow due to aggressive CapEx, with the pessimism further fed by the management's raised FY2026 guidance.Otherwise, Q2 seasonally reports lower cash flows, with the richer TTM cash flow/revenue ratio of 41.6% and the growing cloud backlog mitigating overbuilding concerns.These developments underscore GOOG's AI-driven growth pains, since hefty CapEx must first happen before rich compute/ad monetization may occur.Despite the premium valuations, GOOG's strong balance sheet, oversold technicals, and rich upside potential to my LTPT of $431.70 justify the upgraded Buy rating.Short-term risks include insider selling, SPCX lockup expiries, and seasonal weakness in August/September, with a Buy Zone in the $290s–$320s offering better entries. Techa Tungateja/iStock via Getty Images
I previously downgraded Alphabet Inc., aka Google (GOOG, GOOGL, GOOG:CA), as a Hold in May 2026, attributed to the reduced margin of safety from the outsized rally in April/early May 2026.
In this article, I
15.98K Followers
Analyst’s Disclosure: I/we have a beneficial long position in the shares of GOOG either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
The analysis is provided exclusively for informational purposes and should not be considered professional investment advice. Before investing, please conduct personal in-depth research and utmost due diligence, as there are many risks associated with the trade, including capital loss.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
SummaryAccording to Visible Alpha consensus, Amazon's total revenue for North America of $113.8 billion expected for Q2 edged upward since the February 2026 release.The International operating profit margin range is more extreme at 1.7% to 13.4%, with consensus settling at 4.2%.Given the current backdrop and increasing energy and chip prices, there are questions about whether the Company will raise its full year CapEx guidance.hapabapa/iStock Editorial via Getty Images
What's happening to margins? According to Visible Alpha consensus, Amazon's (AMZN) total revenue for North America of $113.8 billion expected for Q2 has edged upward since the February 2026 release, driven by resilience in Amazon's online
Consumers know Amazon (AMZN -0.70%) best for its retail footprint. Investors, who tend to do a deeper dive on the company, tend to focus on the profitability of Amazon Web Services and Amazon's AI business.
Nonetheless, one other source of revenue has driven higher growth. Better still, that business directly leverages the company's e-commerce site, which is visited by an estimated 2.2 billion people monthly.
Image source: The Motley Fool.
Amazon's lesser-known business segment Investors often forget about Amazon's advertising services business.
Advertising services generated over $17 billion in net sales in the first quarter of 2026, about 9.5% of the company's total. On a trailing-12-month basis, it grew by 24% year over year. That was well above the 17% net sales growth for the overall company, and third only to AWS and Amazon's "other" category in terms of growth.
Admittedly, Amazon itself is probably to blame for this segment attracting relatively little attention. The only metric the company publishes for this business is net sales. Moreover, Amazon divides its advertising services revenues among the North America and international segments, and offers no clarity about how much it contributes to each of them.
Today's Change
(
-0.70
%) $
-1.64
Current Price
$
232.02
So investors have no idea how much operating income the ad business generates. This is significant because such ad businesses tend to have little additional overhead as they scale. Since Amazon has underperformed in 2026, knowing more about how that segment is performing could give investors a reason to buy the stock.
Ultimately, the outlook for the advertising business is probably an excellent reason to buy Amazon stock. It will probably remain a vibrant growth area for the company. Furthermore, even if Amazon chooses not to provide more clarity on how advertising benefits the company's financials, having a major business that's growing as fast as its advertising services unit is can only be good for the consumer discretionary stock over the long term.
Will Healy has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Amazon. The Motley Fool has a disclosure policy.
AMD's Advancing AI 2026 event transformed the company into a full-stack AI infrastructure provider with Helios, MI450, and Zen 6 Venice platforms. Microsoft, Meta, and OpenAI validated AMD's strategy through major AI infrastructure commitments, significantly expanding its long-term revenue opportunity. Consensus expects Q2 revenue of $11.31 billion and EPS of $1.61, while analysts issued 35 EPS upgrades and zero revenue downgrades.
Warren Buffett has never been shy about the great businesses he let slip through his fingers. One of the most painful was McDonald's (MCD +0.75%), which Berkshire Hathaway (BRKB +0.79%) (BRKA +1.14%) sold in the late 1990s in a move Buffett flatly called "a very big mistake." Berkshire has passed on the stock ever since. I think Greg Abel, Berkshire's new chief executive officer, will eventually buy it back, and the reason is simple: McDonald's is a textbook Berkshire business.
Today's Change
(
0.75
%) $
1.96
Current Price
$
264.76
The mold McDonald's fits Forget the burgers for a moment. McDonald's is best understood as a real estate and royalty machine wearing a fast-food uniform. Roughly 95% of its restaurants are run by franchisees, which means McDonald's itself collects high-margin franchise fees and rent on prime real estate while its operators shoulder the day-to-day risk of running the restaurants. The result is capital-light, remarkably predictable cash flow, exactly the quality Buffett spent his career hunting for.
Layer on the rest of the checklist and the fit is almost eerie. McDonald's owns one of the most recognized brands on earth, a genuine competitive moat. It has pricing power built over decades. It generates enormous free cash flow. And it has raised its dividend -- which yields about 2.8% -- for nearly 50 consecutive years. A wide moat, durable earnings, dependable and growing cash returns: This is the archetype of the kind of company Berkshire was built to own.
Today's Change
(
0.79
%) $
3.86
Current Price
$
494.71
The one that got away The history stings precisely because Buffett knew all this. At the end of 1996, Berkshire held about 30 million McDonald's shares, a 4.3% stake worth roughly $1.4 billion. Within two years, he had sold, and in his 1998 shareholder letter, he admitted the error in plain language, joking that shareholders would have been better off had he "regularly snuck off to the movies during market hours." That stake would be worth more than $10 billion today, before counting decades of dividends. It is a rare unforced error from the greatest investor of his era, and a reminder that even Buffett sometimes let a wonderful business go.
Image source: Getty Images.
Why Abel might change that Here is where the simple reasoning comes in. Abel has shown he is more willing than the famously price-sensitive Buffett to act decisively and pay a fair price for quality, as his recent moves into large, fully valued businesses suggest. Buying McDonald's would require no leap into unfamiliar territory, no wrestling with a business model he does not understand, which is what kept Buffett out of so many technology names. It is a company Berkshire knows well and already wishes it still owned. For a leader looking to put Berkshire's mountain of cash to work in proven, moat-protected businesses, repurchasing the one that got away is about as natural a move as it gets.
The caveat worth naming To be clear, this is a prediction, not a certainty, and the point is less about guessing Abel's next trade than recognizing what makes a stock Berkshire-worthy. McDonald's is not cheap and Berkshire may well find more compelling values elsewhere. Predictions about any single purchase are educated guesses at best.
Whether Abel actually pulls the trigger, McDonald's is the sort of business long-term investors can own with real confidence: a wide-moat, cash-gushing royalty and real estate operation that even Buffett wished he had never sold. That is the deeper lesson here. Instead of trying to predict Berkshire's next move, study the investing template it uses: durable brands, predictable cash flows, and pricing power, and McDonald's checks every box. If Greg Abel is hunting for Berkshire-worthy consumer businesses, this is the blueprint, and I would not be surprised to see Berkshire own it again.
Pfizer (PFE -0.20%) has a shockingly high dividend yield of 6.8%. The S&P 500 Index (^GSPC +0.05%) has a 1% yield, and the average pharmaceutical stock's yield is roughly 1.5%. Given that huge disparity, it looks like Pfizer's yield is too good to be true.
There are reasons for the high yield that need to be monitored. However, management doesn't seem too worried about the dividend. Here are some reasons why, and why you might want to buy ultra-high-yield Pfizer.
Pfizer's management is focused on maintaining the dividend Pfizer's dividend, like all dividends, is paid at the discretion of the board of directors. That said, the company's management team has been very clear about its support for the dividend. The dividend was mentioned directly on two slides in the first-quarter 2026 earnings presentation. One slide, focused on 2026 capital allocation priorities, stated that the company wants to "maintain and grow our dividend." A second slide, directed at longer-term growth, made "maintain dividend" a stated goal.
Image source: Getty Images.
If the board was actively considering cutting the dividend, management wouldn't likely have mentioned the dividend on those two slides. Meanwhile, it is important to examine what supports the dividend. The answer isn't earnings, which are under pressure right now, because a company's dividend payments appear on its cash flow statement. The number is fairly large for Pfizer, with the first-quarter dividend payment totaling $2.445 billion. Annualize that, and you get nearly $10 billion.
The company generated $2.6 billion from operating activities, which actually covers the dividend. However, the dividend isn't the only thing the company has to pay for. After paying dividends, paying down debt, and investing in its business, the company's cash balance at the end of the first quarter was higher than at the start. And not just a little higher, $560 million higher. The source of the extra cash was Pfizer selling long-term investments. Turning to the balance sheet, the company still has $11.3 billion in long-term investments, in addition to $1.7 billion in cash.
Watch Pfizer's dividend, but there's plenty to support it This isn't meant to suggest that investors should simply ignore the headwinds Pfizer is facing today. While the company looks capable of supporting the dividend, investors are worried about the pharmaceutical company's future, which has pushed the stock lower and the yield higher. That said, most of the problems the company faces are normal for the pharmaceutical industry.
Today's Change
(
-0.20
%) $
-0.05
Current Price
$
24.53
For example, Pfizer has several blockbuster drugs set to lose patent protection. However, its research and development haven't yet produced new drugs to fill the gap. In fact, the company has clearly fallen behind peers in the hot GLP-1 weight-loss space, after it had to stop work on a drug there in 2025. The thing is, R&D doesn't work on a timeline, even though patent expirations do. Sometimes things just don't line up as well as investors would like.
Pfizer has a long and successful history of developing drugs. Notably, in the case of GLP-1 drugs, it quickly adjusted and bought another company with a more attractive drug candidate. And it has numerous drugs working through the approval process beyond it, as well.
Think long-term with Pfizer Pfizer is still a well-run drug company. It is just working through a difficult period, which has Wall Street worried about the future. If you think long-term, however, you may want to consider buying Pfizer and its outsize yield while everyone else is scared. The company is clearly standing behind the dividend, and when you dig a little deeper, it appears to have the wherewithal to keep supporting it.
Three telecom giants reported Q2 earnings over three days, and now that the market has had time to digest, a theme is emerging in the sector.
One positive trend from the trio of reports last week is that telecommunications companies are no longer paying up for growth through promotions or subsidization. All three companies grew earnings per share (EPS) year over year (YOY) in Q2, indicating stronger retention economics and subscriber growth. Additionally, all three increased shareholder returns through buybacks and dividends, a signal to the market that management thinks it's sitting on a cheap stock.
To choose a winner from Q2, we’ll need to break down the earnings reports in greater detail. Despite earnings, subscriber, and cash flow growth, not every stock responded the same way after its release. The sector as a whole might be its healthiest in years, but not every carrier is capturing upside in the same way.
Get AT&T alerts:
AT&T: Q2 Metrics Show Convergence Thesis Unlocking New Growth OpportunitiesOverall MarketRank™100th Percentile
Analyst RatingModerate Buy
Upside/Downside21.3% Upside
Short Interest LevelHealthy
Dividend StrengthStrong
News Sentiment0.77 Insider TradingN/A
Proj. Earnings Growth9.48%
See Full Analysis
Shares of AT&T Inc. NYSE: T popped more than 3% following its July 22 earnings release, driven by rapid growth and low churn as its services converge. In its Q2 2026 results, the company reported a clear EPS beat and a slight revenue miss, but the underlying numbers are the true driver of the reaction. AT&T added 432,000 postpaid phone subscribers and 646,000 internet subscribers, with more than 147,000 being new accounts, not just extra lines. Home internet service is a key area, with revenue growing 27% year-over-year (YOY), and management expects fiber internet to reach more than 40 million households by the end of the year.
Another bullish beacon is the impressively low churn rates in Q2 despite carrier price increases. Postpaid wireless churn declined to 0.86% YOY, indicating that fewer than 1% of customers cancel their plans each month. Additionally, 42% of home internet customers now subscribe to AT&T wireless, supporting the ‘convergence’ thesis of selling wireless and internet services to the same households. The Q2 metrics show that this strategy is not only driving growth and earnings but also decreasing churn rates.
Management reaffirmed full-year EPS guidance of $2.25 to $2.35 and free cash flow guidance of $18 billion while committing to $45 billion in shareholder returns through 2028. The share repurchase program was increased from $8 billion to $10 billion, as CEO John Stankey cited improved cash flow and the stock's value (10.29 times forward earnings). If there’s one fly in the ointment, it’s the dividend, which has remained frozen at $1.11 annually since 2022 and continues to be stagnant despite the capital return commitments.
T-Mobile US Inc. NASDAQ: TMUS is only one of three to sell off following its Q2 2026 earnings release, which might seem odd given that it beat EPS estimates by more than 15% and raised adjusted free cash flow guidance to a range of $18.4 billion to $18.8 billion. But while the company grew subscribers above consensus, the 277,000 total postpaid net accounts additions represented a 13% YOY decline.
T-Mobile doesn’t publish phone churn rates (only account churn rates), but management prepared the market for a weak Q3 due to “rate plan modernization,” i.e., price hikes. Q3 postpaid net account guidance of just 250,000 adds likely triggered the sell-off. Disappointing results following a strong start to the year in Q1, and the market punished the missteps.
It should be noted that despite the weak subs and troublesome guidance, the earnings growth does appear real. Average revenue per account (ARPA) grew 2% to $152.91, and management guided full-year ARPA to 2.5% to 3%. T-Mobile is deliberately trading volume for monetization, accepting lower subscriber growth in exchange.
Verizon: The Cash Flow King Posts Biggest Upside SurpriseOverall MarketRank™93rd Percentile
Analyst RatingHold
Upside/Downside8.0% Upside
Short Interest LevelHealthy
Dividend StrengthStrong
News Sentiment0.71 Insider TradingN/A
Proj. Earnings Growth6.02%
See Full Analysis
Verizon Communications Inc. NYSE: VZ called the game this quarter thanks to a massive subscriber beat and guidance raise. Expectations were high coming into the Q2 2026 report, but the company surpassed EPS projections (6.6% YOY growth) despite a roughly 2.5% revenue miss vs. consensus. However, the most impressive numbers were the subscriber metrics. Verizon added 184,000 postpaid phone nets in Q2, smashing the consensus expectation of 106,000 and a swift reversal from Q2 2025 when the company lost phone subscribers. The company also added 348,000 broadband subs, bringing the total first-half adds over one million. Phone churn improved 84 basis points, an impressive feat when paired with lower acquisition and retention costs.
Management expects mobility and broadband service revenue to grow 3% in Q3 and 4% in Q4, and boosted full-year EPS estimates to $4.99 to $5.04 and free cash flow estimates to $21.9 billion to $22.1 billion. The cash influx strengthened Verizon’s industry-best dividend, which now yields 6.25% and absorbs only about 31% of free cash flow. Verizon also has a 20-year track record of dividend payout increases, making it the most shareholder-friendly of the major telecoms.
If Verizon’s report contained a red flag, it's that the record profitability and cash flow sit on declining revenue. Management expects revenue growth to pick up in the second half of the year, but this guidance projection is now the most crucial for any of the three major telecoms. A strong Q3 is needed to confirm which trajectory is real.
Should You Invest $1,000 in AT&T Right Now?Before you consider AT&T, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AT&T wasn't on the list.
While AT&T currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.
"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Analyst’s Disclosure: I/we have a beneficial long position in the shares of NEE either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Disclaimer: I am not an investment advisor or professional. This article is my own personal opinion and is not meant to be a recommendation of the purchase or sale of stock. The investments and strategies discussed within this article are solely my personal opinions and commentary on the subject. This article has been written for research and educational purposes only. Anything written in this article does not take into account the reader’s particular investment objectives, financial situation, needs, or personal circumstances and is not intended to be specific to you. Investors should conduct their own research before investing to see if the companies discussed in this article fit into their portfolio parameters. Just because something may be an enticing investment for myself or someone else, it may not be the correct investment for you.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
As demand rises for specialized medications like GLP-1s, logistics companies including UPS and FedEx are adapting their strategies to be able to better ship and store those pharmaceuticals.
Most injectable GLP-1 medications, including Novo Nordisk's Ozempic and Wegovy and Eli Lilly's Mounjaro and Zepbound, require refrigerated storage for shipment.
The Covid pandemic put healthcare logistics at center stage in 2020, as the shipping of temperature-controlled vaccines quickly became a crucial part of keeping the virus at bay. And as more money has been poured into new pharmaceutical innovations, the transportation of those products have come under the spotlight.
Logistics companies are now investing millions of dollars and strengthening dozens of temperature-controlled facilities to tap into the market.
In June, UPS announced a new $48 million investment in temperature-controlled facilities as it sees a growing demand for critical treatments. According to Growth Market Reports, the demand for temperature-sensitive biologics is projected to grow at an 8.3% compound annual growth rate through 2033 and reach a market value of roughly $39.1 billion.
Obesity and diabetes drugs, meanwhile, have been booming in popularity. A July Gallup poll found that 11% of Americans take GLP-1 medications for weight loss purposes in 2026, up from just 3% in 2024.
But if they're not stored and shipped at the correct temperature, they risk losing their efficacy.
The Food and Drug Administration has warned that improper storage during shipping can affect the medicine's quality and recommends patients do not use GLP-1 drugs that arrive "warm or with insufficient refrigeration."
Other biologics, like some vaccines, insulin and antibiotics, also require specialized shipment to maintain efficacy. For logistics companies, that means ensuring the proper storage and movement every step of the way.
Bulking upHealthcare logistics have proven to be one of UPS' biggest opportunities. On an earnings call with analysts in April, CEO Carol Tomé said the company's global healthcare portfolio has gained market share every year since 2021, generating its first ever $3 billion healthcare revenue quarter in the first quarter of this year.
UPS President of Healthcare John Bolla told CNBC that the company is seeing more healthcare companies looking for partners to keep up with the volume.
"One of the biggest opportunities we see is supporting the shift toward more specialized therapies and more care delivered outside of traditional healthcare settings," Bolla said.
He said UPS is experiencing "rapid growth" in biologics, cell and gene therapies, though the biggest challenge is that the margin for error is small — even a brief stray from the correct temperature can ruin the medicines, Bolla said.
"But that's also what's creating such a significant opportunity in healthcare logistics," he said. "As treatments become more specialized and supply chains become more complex, healthcare companies need partners that can provide not just temperature-controlled storage or transportation, but end-to-end visibility, control and reliability across the entire network."
FedEx is also tapping into the trend, launching a life sciences organization earlier this month specifically to support the movement of pharmaceuticals and other healthcare products.
On an earnings call in June, FedEx's Chief Customer Officer Brie Carere told analysts that healthcare transportation revenue in fiscal year 2026 reached nearly $10 billion.
"We're building end-to-end solutions focused on global pharma customers, and what's so important with global pharma is that you have to recognize that there's a patient at the end of every delivery or someone that's waiting to be treated," said Nick Gennari, FedEx's president of healthcare. "So we take this very, very seriously."
With GLP-1s specifically, Gennari said there's an increasing complexity to delivering those medications, with forms ranging from injectables to oral pills and going direct-to-consumer. But with that complexity comes a growth opportunity for FedEx, which he said is "ideally positioned."
Gennari said FedEx has specialized technology, including its machine learning engine that allows customers to see product movement with predictive abilities, as well as its technology that identifies healthcare products and treats each differently depending on its unique needs.
Gennari also said he's "very comfortable" with the company's base capabilities and its plans for expansion, including cold-chain logistics.
"Much of the infrastructure that's required to be successful in this space, we already have. We have the airline; we have an incredible schedule; we have the lift capabilities. The network is hardened and works very well," he said.
Complex supply chainsC.H. Robinson told CNBC the logistics company had surpassed $1 billion in revenue in healthcare logistics alone over the past year, largely due to the growth in GLP-1 drugs, as it has been investing in temperature-controlled facilities.
"You need to really have that end-to-end connectivity, so you've got to have a really nice network and infrastructure built out in order to properly service the healthcare customers," said Ronnie Davis, the company's vice president of North American surface transportation.
Davis said the supply chain for medications has also become more complicated. In addition to requiring refrigeration, many drugs have a short shelf life and need to be delivered in precise windows of time.
"A lot of the innovation has been on getting the drugs to the market," Davis said. "I think what you're starting to see is that's really putting stress on the capabilities of the cold chain supply chains in the marketplace. … With the rise of GLP-1s and other specialized medicine, it's really creating a competitive nature for the same refrigerated supply resources that are there and, quite candidly, that supply is not unlimited, it's constrained."
Davis said C.H. Robinson is working to amp up its capabilities, especially to keep up with the higher volume. At the same time, he added, pharma companies are also trying to get creative to bring their products to market with a longer shelf life.
That innovation is also intersecting with the growth of artificial intelligence capabilities, according to Hendrik Venter, CEO of DHL Supply Chain. The logistics company uses AI to monitor critical life science products, tracking temperatures and anticipating where an issue might happen.
"You're seeing the industry moving from conventional to biopharma," Venter told CNBC. "You need to have a supply chain that is resilient and capable of shipping in all of these various temperature zones."
The company announced last year that it plans to invest 2 billion euros ($2.25 billion) in health logistics by 2030, with half of that allocated to the Americas.
A lot of pharmaceutical companies are also outsourcing their warehousing activities to DHL, Venter said. The company takes over those facilities, manages them and integrates them into the rest of their network.
DHL launched a pharmaceutical air corridor around the world, with a dedicated aircraft and connected network that ensures the drugs are not being shipped through separate regulatory environments.
"You cannot lose a shipment. You cannot replace it. It needs to be delivered on time, every time, in the right quality and temperatures," Venter said. "So we continue to selectively look at how to strengthen that network."
New York, New York--(Newsfile Corp. - July 25, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of First Solar, Inc. (NASDAQ: FSLR) between February 26, 2025 and February 24, 2026, inclusive (the "Class Period"), of the important August 24, 2026 lead plaintiff deadline.
SO WHAT: If you purchased First Solar securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the First Solar class action, go to https://rosenlegal.com/cases/first-solar-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 24, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made materially false and misleading statements and/or failed to disclose that: (1) defendants had overstated First Solar's capacity to manage the impact of U.S. tariff policy on First Solar's business; (2) defendants understated the extent to which its responses to U.S. tariff policy, including the intentional underutilization of production facilities in Malaysia and Vietnam, and attempted relocation of production to the U.S., were likely to negatively impact First Solar's projected performance in the 2026 fiscal year; and (3) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the First Solar class action, go to https://rosenlegal.com/cases/first-solar-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/306461
Source: The Rosen Law Firm PA
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
The AI boom has transformed semiconductors from a cyclical business into one of the world’s most strategically important industries. Memory chips, once viewed as commodity components, have become a bottleneck for everything from smartphones to AI servers. That has given suppliers unusual pricing power while forcing customers to rethink their supply chains.
Nowhere is that tension more visible than in Apple‘s (NASDAQ:AAPL | AAPL Price Prediction) reported push to buy lower-cost memory from China’s ChangXin Memory Technologies (CXMT), even though the company has been blacklisted by the U.S. government because of its ties to the Chinese military and state. The dispute says as much about the future of the memory industry as it does about Apple.
Apple Wants Cheaper Memory, but the Politics Are Expensive According to multiple media reports, Apple is lobbying the Trump administration for permission to source memory from CXMT. Buying chips from the company is reportedly not outright illegal, but doing so without government approval could expose Apple to political criticism and reputational damage because of CXMT’s placement on U.S. restricted-entity lists.
Apple’s reported argument is straightforward. It claims Micron Technology (NASDAQ:MU) is taking advantage of today’s tight memory market by charging excessive prices. That criticism comes after Micron’s gross margins climbed above 80% as AI demand continues to outpace supply.
Ironically, Apple has long been known for charging premium prices itself. Just weeks ago, CEO Tim Cook announced price increases of roughly 20% across several MacBook and iPad models, saying Apple could no longer absorb higher component costs. Cook even described today’s memory shortage as a “100-year flood” event.
That makes Apple’s accusations of price gouging harder to separate from its own efforts to protect product margins.
The company’s argument is that large device makers, including Apple, spent years squeezing suppliers for lower prices. Those aggressive negotiations hurt profitability across the memory industry and discouraged investment in new manufacturing capacity. When generative AI suddenly sent demand soaring, the industry did not have enough supply.
Micron argues that today’s higher prices reflect genuine scarcity and tens of billions of dollars being invested in new fabrication plants, including major U.S. manufacturing projects supported by the CHIPS Act.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Apple didn't make the cut. Grab the names FREE today.
Company AI Memory Products Highest-Margin Business Micron HBM, DDR5, LPDDR5X High-bandwidth memory (HBM) CXMT DDR5, LPDDR5X, LPDDR4X, RDIMM, MRDIMM Conventional DRAM That distinction matters. CXMT manufactures mainstream DRAM used in PCs, smartphones, and enterprise servers. It does not produce high-bandwidth memory (HBM), the advanced chips powering Nvidia‘s (NASDAQ:NVDA) AI accelerators.
Because HBM commands much higher prices and margins than commodity DRAM, it remains the engine behind Micron’s earnings growth.
The Bigger Story Isn’t Apple Surprisingly, this dispute has less to do with Apple than with how valuable advanced memory has become.
Apple wants lower-cost conventional DRAM to protect margins on consumer devices. Micron wants pricing that supports years of capital spending needed to expand production. Meanwhile, the fastest-growing part of the industry — HBM — faces little competitive pressure because only a handful of companies can manufacture it at scale.
That leaves Micron in an enviable position. Even if Apple eventually receives approval to buy some lower-cost conventional memory from CXMT, it would do little to weaken Micron’s leadership in AI memory, where demand continues to outstrip supply.
Key Takeaway In short, Apple’s reported campaign highlights the growing tension between technology companies trying to control costs and semiconductor manufacturers finally earning healthy returns after years of razor-thin profitability. Granted, Apple has every incentive to lower its bill of materials. But accusing suppliers of gouging rings hollow when Apple has long charged premium prices for its products and raised its own prices by roughly 20% while defending those increases as necessary.
For investors, the bigger investment thesis hasn’t changed. Conventional DRAM pricing may fluctuate as new suppliers emerge, but HBM remains the profit center that matters most. As long as AI infrastructure spending continues at today’s pace, Micron’s competitive advantage rests far less on commodity memory pricing than on its ability to supply the premium chips powering the AI revolution. Ultimately, that’s the market smart investors should be watching.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Apple didn't make the cut. Grab the names FREE today.
Micron Technology (MU -7.24%) stock has been on a wild ride between June 22 and July 22, trading as low as $804 and as high as $1,255. Given the volatile price swings over that time, when Micron's stock price falls below $1,000, investors may be wondering whether it's a "buy-the-dip" moment or if it's better to stay on the sidelines.
Based on the median price target from 54 analysts tracked by CNN, here's what the math suggests about whether buying Micron below $1,000 has a favorable risk-to-reward setup.
Image source: The Motley Fool.
Where Micron stock could be in the next 12 months According to 54 analysts, the median price target for Micron over the next year is $1,600. We can work out what a return would look like if Micron were to reach that price target based on two recent closing prices.
On July 20, Micron closed at $865.46 per share, so if the stock were to reach $1,600, that would have been a gain of 84.8%. From its closing price of $959.48 on July 22, reaching that $1,600 target would be a gain of 66.7%.
To offer an even wider lens on the risk-to-reward setup, the highest price target among the 52 analysts tracked by CNN was $2,200, while the lowest was $361.
Today's Change
(
-7.24
%) $
-71.69
Current Price
$
918.52
What price targets offer Price targets are estimates, and there are not only internal factors within the company, but also external factors that analysts can't envision that could affect those estimates over the next 12 months. That's why price targets aren't guaranteed to come true, and they shouldn't be used as the main reason for buying a stock.
That said, it does help gauge the upside potential of a stock and what might happen under the worst-case scenario. Based on the hypotheticals shared earlier, in which Micron could trade up to around 85% higher over the next 12 months, investors who can handle the risk and price swings may benefit from investing when Micron falls below $1,000.
Expectations matter A stock returning another 60% to 85% over the next year is exceptional. And as memory and storage chip shortages are expected to continue for the foreseeable future, Micron is poised to continue benefiting and could offer those kinds of returns. But those potential gains may still manage to disappoint some investors.
As of this writing, the stock has climbed more than 780% over the past 12 months. In comparison, a gain in a range between 60% and 85% may sound like a letdown to anyone just investing in Micron now.
There's also the fact that there's no guarantee the stock price will climb that high or provide a gain at all. That makes Micron a more attractive investment for those who are still comfortable if it doesn't reach a specific price target over the next year and view it more as a long-term investment.
Memory and storage demand from artificial intelligence (AI) is expected to keep growing, so as long as Micron keeps meeting that demand from AI and keeps its margins high, the stock price can continue climbing.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Bohdan Kucheriavyi is not a financial/investment advisor, broker, or dealer. He's solely sharing personal experience and opinion; therefore, all strategies, tips, suggestions, and recommendations shared are solely for informational purposes. There are risks associated with investing in securities. Investing in stocks, bonds, options, exchange-traded funds, mutual funds, and money market funds involves the risk of loss. Loss of principal is possible. Some high-risk investments may use leverage, which will accentuate gains & losses. Foreign investing involves special risks, including greater volatility and political, economic, and currency risks and differences in accounting methods. A security’s or a firm’s past investment performance is not a guarantee or predictor of future investment performance.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
ServiceNow is rated a strong buy, driven by its strategic pivot to become the AI agent control tower for enterprises. NOW's aggressive M&A, including Armis and Veza, directly addresses governance and security bottlenecks critical for enterprise AI adoption. Transition away from seat-based pricing and core ticketing disruption positions NOW defensively against SaaS commoditization and AI-driven competition.
Rabobank expects renewed pressure on Pound exchange rates as concerns over Prime Minister Andy Burnham’s spending plans unsettle the gilt market. The British Pound concluded this trading week facing a difficult combination of political uncertainty, elevated UK bond yields and doubts over how the new government intends to fund its policy agenda.
UK economists at Rabobank say the initial market response to Burnham’s cabinet and early policy announcements has been notably cautious.
Latest — Exchange Rates:
Pound to Euro (GBP/EUR): 1.171822 (+0.14%)
Pound to Dollar (GBP/USD): 1.332498 (+0.09%)
Euro to Dollar (EUR/USD): 1.137117 (-0.05%)
The UK 10-year gilt yield has moved above 5.0%, while Pound Sterling has ranked as the weakest G10 currency over the latest one-day period.
Although the appointment of an experienced Chancellor has offered some reassurance, the bank warns that uncertainty surrounding the government’s fiscal strategy could keep both gilts and the Pound under pressure.
Rabobank analysts expect EUR/GBP to rise to 0.8650 over the next three months and sees scope for GBP/USD to fall back towards 1.3200.
At current rates, those forecasts imply a weaker Pound against both the Euro and the US Dollar.
Rabobank Warns Burnham’s Honeymoon Could Be Brief Rabobank says the appointment of Healey as Chancellor is a stabilising factor because the country’s finances have been placed in the hands of an experienced politician with previous Treasury exposure and respect across Parliament.
However, the larger question is how Burnham plans to finance his agenda.
The Prime Minister has said he intends to use “flexibility” within the fiscal rules, which Rabobank says could point towards placing some infrastructure-related debt on the balance sheets of public financial institutions.
Although such borrowing might sit outside the most closely watched fiscal measures, it would still need to be absorbed by the bond market.
“The market will be wary about whether this constitutes ‘back door’ funding,” Rabobank says.
The government’s first cost-of-living measure is a reduction in VAT on household electricity bills from October.
Officials have indicated that the measure will be funded by cancelling the previous government’s digital identity programme, although reports have raised doubts over whether that scheme was fully funded in the first place.
Rabobank notes that use of greater flexibility within the fiscal rules could potentially mobilise an additional £16 billion for infrastructure projects over the remainder of the decade.
Infrastructure investment could improve productivity in parts of the UK outside London and the South East, but those benefits may take years to materialise.
Burnam, by contrast, faces a general election in less than three years.
That leaves the government under pressure to deliver visible improvements quickly, increasing the risk that spending commitments expand before the economic benefits become apparent.
“The market is now bracing itself for a list of further announcements,” Rabobank says.
“This suggests that funding issues will remain at the fore of the market’s mind and hints that Burnham’s honeymoon may be short-lived.”
Gilt Market Particularly Sensitive The latest UK borrowing figures were slightly better than expected for June, but borrowing over the first three months of the fiscal year remains above projections from the Office for Budget Responsibility.
At an early stage of the financial year, that overshoot might ordinarily attract limited attention.
Rabobank argues that the political backdrop makes investors more sensitive than usual.
Burnham is associated with the softer left of the Labour Party and has said he wants government to become less reliant on what he described as the “imperial” Treasury.
Against this backdrop, the bond market is likely to demand clear reassurance that new spending plans will remain compatible with the fiscal rules.
Rabobank also highlights structural vulnerabilities in the UK economy.
The country has a low household savings ratio and a substantial current-account deficit, increasing its dependence on overseas capital.
These characteristics can amplify market reactions when confidence deteriorates.
“The UK may not have the largest debt-to-GDP ratio in the developed world, but arguably it has one of the most sensitive debt markets,” Rabobank says.
Lower BoE Expectations Are Another Pound Risk The reduction in VAT on household electricity bills should mechanically lower inflation.
Rabobank also expects headline UK CPI inflation to ease to 2.7% year on year, offering some short-term reassurance to the gilt market.
The inflation outlook remains complicated by higher spot energy prices following the escalation in the US-Iran conflict, but Rabobank believes current Bank of England pricing is too aggressive.
Markets are pricing approximately 43 basis points of BoE tightening over the next six months.
Rabobank expects the central bank to avoid raising rates this year.
“On our view, this is overdone and a reduction in market expectations for BoE policy tightening is another headwind for the pound,” the bank says.
This is important because elevated UK interest-rate expectations have provided Sterling with some protection against fiscal and political concerns.
Were investors to remove those expected rate increases, the Pound would lose part of its yield advantage at the same time as the gilt market remains uneasy about government borrowing.
Image: Exchange Rates UK Research polling shows GBP/USD median bank forecast chart showing the live rate near 1.3325, a Q3 median near 1.32 and the longer-term forecast path GBP/USD Forecast: 1.3200 Comes Back Into View GBP/USD ended the latest session around 1.3325, recording a modest daily gain after Thursday’s 0.47% decline.
The pair has nevertheless fallen by more than two cents from the 15 July close near 1.3540 and remains well below July’s high of 1.3558.
The short-term chart shows Sterling attempting to stabilise around 1.3320 after repeated failures to sustain advances above 1.3340.
GBP/USD is trading close to the 20-period moving average at 1.3327 and session VWAP near 1.3323.
That positioning suggests the pair is currently balanced around its immediate fair-value area rather than developing a strong recovery.
The 200-period moving average near 1.3340 remains the more important overhead barrier.
A recent rebound failed close to that level, confirming the 1.3340-1.3350 region as the first substantial resistance zone.
RSI has recovered to approximately 48 from below 40, showing that downside momentum has eased.
However, the indicator remains below 50 and does not yet signal that buyers have regained control.
Initial support is located around 1.3310, followed by 1.3290.
Rabobank’s 1.3200 objective would come into clearer view following a break below these levels, while July’s low at 1.3221 represents a significant intermediate support area.
On the upside, a sustained move above 1.3340 would reduce immediate downside pressure, although GBP/USD would still need to recover through 1.3400 to suggest the broader July correction has ended.
Image: GBP/USD 15-minute chart with 1.3310 support, 1.3340 resistance and Rabobank’s 1.3200 forecast marked The median bank forecast path also points to near-term weakness before a later recovery.
The Q3 2026 median projection is close to 1.3200, broadly matching Rabobank’s three-month forecast, while the consensus path then rises towards 1.35 in early 2027 and approximately 1.38 by the end of that year.
Rabobank’s view is therefore consistent with the wider consensus in anticipating near-term pressure, although it does not rule out a longer-term recovery.
Image: EUR/GBP survey poll forecasts July 2026 EUR/GBP Forecast: Rabobank Targets 0.8650 EUR/GBP closed around 0.8534 after falling 0.14% in the latest session.
The cross has recovered from July’s low near 0.8455, but remains almost 1% lower for the month and below the July opening level near 0.8614.
The 15-minute chart shows that EUR/GBP has surrendered part of its recent rebound after failing above 0.8550.
The cross is trading close to its 20-period moving average near 0.8533, but remains below session VWAP around 0.8541 and beneath the 200-period moving average near 0.8539.
This leaves the immediate technical picture mixed.
The latest recovery from below 0.8530 shows that selling pressure has moderated, while RSI near 46 has moved above its signal line.
However, the cross remains below the neutral 50 level and has yet to overcome the main intraday resistance cluster.
Initial resistance is located around 0.8539-0.8542, followed by 0.8547 and the recent highs around 0.8550-0.8555.
A break through that area would strengthen the case for a return towards 0.8600.
Rabobank’s 0.8650 forecast lies above the current technical range and would require a more decisive deterioration in Sterling sentiment.
On the downside, support is located around 0.8530, followed by 0.8525.
A break below these levels would weaken the immediate recovery and raise the risk of a renewed move towards 0.8500.
Image: EUR/GBP 15-minute chart with 0.8530 support, 0.8550 resistance The wider bank consensus also leans towards a higher EUR/GBP rate over the coming quarters.
The median forecast stands close to 0.8700 from the third quarter of 2026 through early 2028, before easing towards 0.8600 and then 0.8450 by the end of 2028.
Rabobank’s 0.8650 target is therefore slightly below the near-term consensus median but still implies a meaningful Sterling decline from current levels.
Pound Sterling: Rabobank’s forecasts leave GBP exposed on two fronts Against the Euro, the bank expects EUR/GBP to rise towards 0.8650 as investors question the government’s fiscal plans and reassess the likelihood of Bank of England tightening.
Against the Dollar, it sees GBP/USD falling towards 1.3200 as political uncertainty, gilt-market sensitivity and lower UK rate expectations weigh on the Pound.
The technical charts show that neither move has yet been fully confirmed.
GBP/USD is attempting to stabilise around 1.3320, while EUR/GBP remains below resistance around 0.8550.
However, the fundamental risks identified by Rabobank remain unresolved.
A reduction in expected BoE tightening would remove an important source of Sterling support, while further spending announcements without a convincing funding plan could renew pressure on gilts.
The base case is therefore for Pound Sterling to remain vulnerable, with a GBP/USD break below 1.3290 strengthening the path towards 1.3200 and an EUR/GBP move above 0.8550 opening the way towards Rabobank’s 0.8650 target.
MUFG believes gold remains well supported despite higher US Treasury yields, arguing that persistent geopolitical tensions are generating enough safe-haven demand to offset the headwinds from a more hawkish interest-rate outlook.
The price of Gold in US dollars (XAU/USD) traded around $4,100 on Friday after extending its rebound from recent lows below $4,000, with investors continuing to favour the precious metal as conflict in the Middle East shows little sign of easing.
Image: Gold price in USD - 1 day chart The Gold price has recovered steadily over recent sessions as geopolitical risks intensified following continued US strikes on Iran, renewed threats around the Strait of Hormuz and further Houthi attacks on shipping in the Red Sea.
MUFG says those developments have encouraged investors to buy gold despite the negative impact that higher oil prices are having on inflation expectations.
"Gold rose above US$4,100/oz as investors continued buying on price weakness amid persistent geopolitical uncertainty in the Middle East."
The bank also notes that inflows into gold-backed exchange-traded funds have strengthened markedly.
"Inflows into gold-backed ETFs recorded their largest daily increase in more than a month."
Normally, rising Treasury yields and expectations of higher interest rates would weigh heavily on gold because the metal offers no income.
However, MUFG believes investors are currently placing greater emphasis on geopolitical uncertainty.
"The latest rebound suggests geopolitical risks are outweighing concerns over higher interest rates for now."
The bank adds that higher oil prices are complicating the outlook by reinforcing inflation concerns and increasing the possibility that the Federal Reserve keeps monetary policy tighter for longer.
"Rising oil prices have reinforced inflation concerns, prompting markets to weigh the prospect of a more hawkish Fed."
Image: Gold price vs USD - 3 month chart Although MUFG remains constructive on gold in the near term, it expects gains to become more measured if US bond yields continue rising.
"Elevated Treasury yields are likely to limit the pace of further gains in gold."
For now, however, the bank believes continued geopolitical uncertainty across the Middle East should keep safe-haven demand elevated, providing ongoing support for bullion even as investors reassess the outlook for US interest rates.
Exchange Rates UK Research Our currency coverage draws on live market data, official economic releases and published bank research.
Founder's ClubSwingTraderLeaderboardMarketSurgeeIBDIBD DigitalIBD LiveCustomer Center
My Stock Lists
Email Preferences
Help & Support
Sign Out
Search stocks or keywords
Sections
My IBD
MARKET TREND
STOCK LISTS
STOCK RESEARCH
NEWSECONOMY
VIDEOS & PODCASTS
HOW TO INVESTEDUCATIONAL RESOURCESStoreMy Products
Founder's ClubSwingTraderLeaderboardMarketSurgeeIBDIBD DigitalIBD Live
Recently Searched
Bank of America Pops To New High, Leads 17 Newcomers To IBD 50, Other Top Stock lists
Blue Chips Lead Stock Market, But Memory, Chip Stocks Take Heat As Nasdaq Breaches Key Level
Dow Jones Futures: Apple Earnings, Iran News, Fed Meeting Loom As AI Stocks Sell Off As AI-related stocks weaken, investors are rotating into other sectors, such as energy and health care. Thus, this week's stocks to watch include Energy Transfer (ET), Eli Lilly (LLY), ATI (ATI) and J.B. Hunt Transport Services (JBHT). But Dell Technologies (DELL), whose growth is coming largely from AI products, is forming a sturdy base and is a tech stock to…
Weekly Market HighlightsThis week, 706 stocks gained more than 10%, while 888 stocks declined by more than 10%, indicating significant market turbulence.The ov
Enphase Energy (NASDAQ:ENPH | ENPH Price Prediction) has pulled back sharply, making the stock worth a closer look ahead of Q2 earnings on July 28. The solar hardware leader now trades at 19 times forward earnings, holds $474 million in cash, and has opened its products to utilities serving 30 million customer accounts.
Analysts See Meaningful Upside Shares closed at $36.70 on Friday, July 24, down 23.25% from a month ago and 50.23% below the 52-week high of $73.74. The company’s forward P/E sits at 19, while Wall Street’s mean price target is $48.47, implying meaningful upside.
The base case AI model prices the stock’s fair value at $65.66 with 90% confidence. Independent fair-value screens place the stock 18.7% to 20% below intrinsic value.
Management Recently Repurchased Shares Above Today’s Price Enphase closed 2025 with $474.32 million in cash, up 28.5% YoY, and $268.7 million of buyback authorization remaining.
Management repurchased roughly $130 million of stock across the first half of 2025 at average prices of $62.71 and $42.67 per share. Both figures sit above today’s quote. Insiders are already voting with real money, with net buying across 12 recent transactions.
The 30 Million-Customer Catalyst Is Just Getting Started U.S. sell-through demand jumped 21% QoQ in Q4, the strongest reading in over two years. The IQ Meter Collar cleared 52 U.S. utilities serving roughly 30 million customer accounts. Certified battery installers grew from 19,500 to over 22,000. A new safe harbor agreement adds around $68 million over 12 to 24 months.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Enphase Energy didn't make the cut. Grab the names FREE today.
FY2025 revenue grew 10.72% to $1.473 billion, operating income rose 103.81%, and net income expanded 67.68%. EPS beat estimates in three of the last four quarters, including a 22.63% Q4 beat.
Enphase Crushes SolarEdge Where It Matters Most SolarEdge Technologies (NASDAQ:SEDG) is one of Enphase’s primary competitors in residential solar hardware, and reported a Q1 net loss of $57.37 million and carries a Sell rating from BMO Capital with a $36 price target vs a current price of $42.60. Enphase generated $172.13 million of net income and $95.90 million of free cash flow in 2025.
Why Tariffs Do Not Break the Comeback Thesis Reciprocal tariffs are expected to reduce the company’s gross margin by roughly five percentage points through Q1 2026, but Enphase is already absorbing that pressure. Its Q4 non-GAAP gross margin still reached 46.1%, while 1.31 million U.S.-made microinverters qualified for Section 45X production tax credits.
Enphase’s expanding domestic manufacturing footprint should help offset tariff pressure and position the company to benefit from policies favoring U.S. production. For growth-oriented investors, the current valuation appears to reflect the near-term tariff risk without fully recognizing Enphase’s cash position and recovery catalysts.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Enphase Energy didn't make the cut. Grab the names FREE today.
Why sit around and wait all quarter long for a dividend payment where there are monthly dividend stocks available?
Monthly divvies are where the retirement party is at! These income “cheat codes” arrive alongside our bills and recurring expenses. What a concept!
But be careful because some monthly payers don’t pay enough to matter. Take Permian Basin Royalty Trust (PBT), which pays monthly but these divvies add up to just 1.2% annually. Gee, thanks.
PBT Dividend Yield
Ycharts
We need monthly payers that are committed to maximizing not just the frequency of shareholder rewards, but the size of the payout. And we need to shoot high—we shouldn’t settle for anything less than what it would take to retire on dividends alone.
Fortunately for us, many monthly dividend stocks fall within the high-yield acronyms: real estate investment trusts (REITs), business development companies (BDCs) and the like.
MORE FOR YOU
Today, for instance, I’ve put together a five-pack of monthly dividends that shell out an average of 10.6% annually. That means even half a million bucks evenly invested across them would generate a hefty “salary” of $53,000.
Monthly Payers
Contrarian Outlook
Let’s take a look.
Monthly Dividend #1: Healthpeak Properties (DOC)I’ll start with Healthpeak Properties (DOC), a healthcare REIT whose roughly 690 properties include outpatient medical facilities and laboratories, which are leased out to biopharma firms, health systems, physician groups, medical device manufacturers and more.
Healthpeak also deals in senior housing, albeit not as directly as it did just a few months ago. In March, DOC spun off that part of the business with an initial public offering of Janus Living (JAN). It wasn’t a full exit, however. Healthpeak not only retained more than 80% of the newly formed REIT, but it also is Janus’s external manager.
A couple months later, DOC received a much-needed jolt after reporting better-than-expected earnings and upgrading its funds from operations (FFO) outlook. Among the reasons for management’s optimism: The senior housing environment is improving, Janus appears primed to aggressively invest, and a weak laboratories market showed small signs that it’s starting to inflect.
And just this week, Healthpeak announced a $2.1 billion joint venture with Brookfield Asset Management (BAM) that will help DOC to pay down nearer-term debt (though it could be a short-term weight on earnings, too).
Healthpeak’s stock has delivered a year-to-date total return of almost 45% thanks to its summer ramp-up. It’s a welcome development for shareholders that have suffered through a decade-plus downtrend. However, new money is now buying a yield that’s well below historical highs and closer to a longer-term middle ground, while the P/FFO has wafted to just above 13—not wildly overpriced, but not discount territory either.
Monthly Dividend #2: Itau Unibanco Holding (ITUB)Most international companies pay dividends just once or twice a year, and some will even do a lopsided interim-and-final system. That’s practically useless for income planning.
Itaú Unibanco Holding (ITUB) isn’t exactly a conventional payer itself, but it at least doles out something each and every month.
Itaú Unibanco is the largest bank by assets in both Brazil and all of Latin America. It offers consumer banking products like credit cards and loans, but also commercial banking, advisory, real estate lending, life insurance and more. And while it’s headquartered in Brazil, it has operations across the Americas and Europe.
The company has printed bigger top and bottom lines every year since 2020, and it’s coming off a record-breaking first quarter in which it posted a $2.5 billion profit and a return on equity of around 25%. The company is also one of the region’s leaders in digital assets, giving it another potential growth avenue.
ITUB’s distributions are tied to performance, so Itaú Unibanco has increasingly been sharing the wealth with its stockholders. But while it pays much more frequently than most, it still has an odd system.
I’ve written several times about companies with regular-and-supplemental dividend programs. Itaú goes a step farther. The company distributes small monthly payments of “interest on capital” (IOC), but it will also make larger additional IOC payments throughout the year as able, then an actual dividend—usually its biggest payment—once a year.
The monthly payment only comes out to less than half a percent’s worth of yield; the real money is in those larger IOC distributions and the dividend. So while the dividends are a nice sweetener for investors who like ITUB for its growth potential, it’s not an ideal situation for retirement planners reliant on regular income.
Monthly Dividend #3: Gladstone Investment (GAIN)Let’s shift to business development companies, starting with one that has a regular-and-supplemental system like ITUB (but with a much more substantial baseline of income).
For the unfamiliar: BDCs were created by Congress in 1980 to spur investment in small businesses. Traditional banks often shunned smaller companies, either charging extremely high rates to compensate for the risk or outright refusing to lend to them. Enter BDCs, which provide equity, debt and other financing to small businesses that otherwise might not be able to raise capital.
Gladstone Investment (GAIN), for instance, provides financing to lower-middle-market companies that generate EBITDA (earnings before interest, taxes, depreciation and amortization) of between $4 million and $15 million annually, have attractive fundamentals and are run by strong management teams.
GAIN runs a small portfolio of just 29 investment companies right now, largely clustered in the business/consumer services, consumer products and manufacturing industries. Its investments include Phoenix Door Systems (industrial doors), ImageWorks Display (retail display shelving) and Old World Christmas (holiday-geared retail).
Gladstone Investment also stands out for its deal mix. Like with most BDCs, the majority of Gladstone’s financing is debt-based, and currently, all of that debt is floating-rate in nature. But GAIN is happier than most to deal in equity. Gladstone says the average BDC’s equity exposure is between 5% and 10%; its target is closer to 25%. This shields GAIN from interest-rate declines but puts it behind the 8-ball when rates climb.
There’s plenty to like from an operational standpoint. Net asset value has grown by nearly 30% between its fiscal Q1 and its recently reported fiscal Q4. Return on equity is consistently in the double digits and above peers.
The dividend is best described as “good with the potential for greatness.” GAIN’s monthly dividend comes out to a little less than 6%, which is high compared to the average stock and far better than what ITUB offers, but low relative to the BDC space. However, Gladstone Investment also pays supplemental distributions when it locks in gains from its equity investments.
Right now, for instance, Gladstone Investment has gone roughly a year since its last supplemental. It might pay one later this year. It might do so in early 2027. It might be even longer; it’s hard to tell.
Still, it’s a decent income baseline with the potential for more, and it’s paid out by one of the industry’s better names. Pricing could be better, though, with GAIN shares currently trading right around the BDC’s net asset value.
Monthly Dividend #4: PennantPark Floating Rate Capital (PFLT)PennantPark Floating Rate Capital (PFLT) is another BDC that provides financing primarily via floating-rate senior secured loans—mostly first lien—but also through some equity and joint venture investments. Its target companies generate $10 million to $50 million in annual EBITDA.
This “value-added” BDC lends its expertise in specific industries, hence its portfolio focus on five categories: healthcare, consumer, business services, government services and software/technology.
Earlier this year, I wrote that PennantPark Floating Rate’s dividend has routinely outstripped its net investment income (NII), and did so again to close out 2025. The company insisted then that it could keep covering the payout.
PFLT adjusted its monthly dividend program from 10.25 cents per share to an 8-cent regular, as well as supplemental dividends (50% of excess earnings). The first two supplemental dividends since the reduction were 0.33 cents apiece.
But not all dividend cuts are created equally. In the case of PFLT, its dividend cut is more a reflection of lower base rates than any underlying portfolio issues. In fact, the company’s credit quality is high relative to the sector, and sponsor investment activity is improving. Moreover, PFLT continues to trade for a song, priced at a 32% discount to NAV.
Monthly Dividend #5: Invesco Mortgage Capital (IVR)It’s hard to find better yields than in the mortgage REIT (mREIT) space, where double-digit payouts are the norm.
Mortgage REITs borrow at short-term rates, purchase mortgages paying long-term rates, then pocket the spread. Short-term rates are usually lower than long-term rates. But the ideal scenario is that short-term rates are also declining while long-term rates hold steady or also decline. In that scenario, mREITs’ existing mortgages, which were issued when rates were higher, will yield more than newly issued ones (and thus be worth more). On the flip side, rising rates weigh on the value of existing mortgages.
Invesco Mortgage Capital (IVR), for instance, owns “agency” mortgage-backed securities (MBS) from entities like Fannie Mae and Freddie Mac. These securities feel interest-rate pressure too, but it’s not as great because their MBSs are backed by the agencies, and thus they have virtually no default risk. I’ll also note that rising interest rates reduce the risk of prepayment, mostly because mortgage holders are less likely to refinance.
While Invesco Mortgage Capital yields a mouth-watering 18%, mortgage REITs historically have been prone to unstable dividends, and IVR is no different.
Near the end of 2025, IVR announced a modest 6% dividend hike to 36 cents per share to be paid in January. But in January, the company announced it would start to issue monthly dividends of 12 cents per share (so, the same amount each quarter).
Invesco Mortgage Capital has mostly underperformed its peers since COVID, but it has behaved much better over the past year or so. Dividend coverage, per its “earnings available per distribution” (EAD), is fine for now, too. But despite an effectively flat year-to-date performance (even accounting for its massive payout), shares trade at a thin discount to its shrinking book value.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In PicS To Contact Him Directly To Discuss Their Options
If you purchased or acquired PicS Class A Common stock in and/or traceable to PicS' January 30, 2026 initial public offering ("IPO") and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
New York, New York--(Newsfile Corp. - July 25, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against PicS N.V. ("PicS" or the "Company") (NASDAQ: PICS) and reminds investors of the August 4, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) PicS N.V. had conducted an evaluation of its credit evaluation procedures in December 2025 and determined that such procedures were deficient and in need of enhancement; (2) as a result of the new procedures PicS N.V. had implemented in December 2025, PicS N.V. had reclassified approximately R$590 million of exposures previously classified as Stage 2 to Stage 3, leading to an incremental ECL charge of R$88 million in the three months ended December 31, 2025; (3) PicS N.V. had experienced a heightened, but unreported, Stage 3 formation rate of more than 7% in the fourth quarter of 2025 that deviated substantially from the historical results and trends provided in the offering documents; (4) the IPO's offering documents had materially overstated the quality and ability of PicS N.V.'s credit models and user data to inform PicS N.V.'s underwriting practices and to allow PicS N.V. to timely and effectively monitor, assess, and identify adverse credit events, credit risks, and credit deterioration across its portfolio; and (5) PicS N.V. suffered from degradations in customer credit quality and heightened risks of default and loan impairment as a result of its entrance into materially riskier business lines leading up to the IPO, resulting in undisclosed adverse financial and operational trends such as heightened incidents of default, which predated the IPO and were internally projected by PicS N.V. to continue to worsen following the IPO, materially impairing PicS N.V.'s business, operations, and financial results.
On or around January 29, 2026, PicPay conducted its initial public offering ("IPO"), selling 22.86 million Class A common shares priced at $19.00 per share.
Then, on March 18, 2026, PicPay released its fourth quarter 2025 financial results and revealed that, as part of the Company's "annual review of expected credit loss parameters," it had made several "enhancements" to its Expected Credit Loss ("ECL") calculations, and "implemented a stricter policy to accelerate the classification of renegotiated non-performing exposures from Stage 2 to Stage 3." Consequently, "R$590 million of Stage 2 portfolio balances were reclassified to Stage 3, resulting in an ECL increase of R$88 [$17.56 million USD]." Stage 3 is the Company's highest risk category for its credit portfolio.
On this news, PicPay's stock price fell $3.56 per share, or 22.5%, to close at $12.27 per share on March 19, 2026.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding PicS' conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the PicS N.V. class action, go to www.faruqilaw.com/PICS or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Frequently Asked Questions (FAQ) for Investors Regarding the PicS N.V. Securities Class Action Lawsuit:
What is the PicS N.V. securities fraud lawsuit about?
The PicS N.V. securities fraud lawsuit is a federal securities class action alleging that PicS N.V. (NASDAQ: PICS) and its executives made false and misleading statements to investors in connection with the Company's January 30, 2026 IPO by concealing that the Company had already identified deficiencies in its credit evaluation procedures in December 2025, had reclassified approximately R$590 million of exposures from Stage 2 to Stage 3 (its highest credit risk category) resulting in an incremental expected credit loss charge of R$88 million, and was experiencing a Stage 3 formation rate exceeding 7% in Q4 2025 - a significant deviation from the historical trends presented in the IPO's offering documents. As the truth emerged on March 18, 2026, when PicS disclosed these credit portfolio deteriorations as part of its Q4 2025 financial results, PICS shares fell $3.56 per share, or 22.5%, to close at $12.27 - well below the $19.00 IPO price - causing significant losses for investors.
Who may be eligible to participate in the PicS N.V. class action lawsuit?
Investors who purchased PicS N.V. (PICS) Class A common stock in and/or traceable to the Company's January 30, 2026 initial public offering and suffered financial losses may be eligible to participate in the PicS securities class action. Participation as a class member does not require taking any affirmative legal action; eligible investors may recover losses simply by remaining members of the class. Whistleblowers, former PicS employees, and others with relevant information about the Company's conduct are also encouraged to come forward.
What is a lead plaintiff, and how can I seek appointment in the PicS N.V. lawsuit?
A lead plaintiff in the PicS N.V. class action is a court-appointed investor - typically the one with the largest financial interest in the case - who directs and oversees the litigation on behalf of all class members. Any PicS investor who purchased PICS Class A common stock in or traceable to the IPO may move the Court to serve as lead plaintiff through counsel of their choice. The deadline to seek lead plaintiff appointment is August 4, 2026. Importantly, choosing not to seek the lead plaintiff role does not affect an investor's ability to share in any recovery obtained for the class.
What should investors do if they purchased PicS N.V. stock in the IPO?
Investors who purchased PicS N.V. (PICS) Class A common stock in and/or traceable to the January 30, 2026 IPO and suffered losses should contact Faruqi & Faruqi, LLP immediately to discuss their legal rights. The deadline to seek appointment as lead plaintiff in the PicS N.V. securities class action is August 4, 2026. To speak directly with securities litigation partner Josh Wilson, call 877-247-4292 or 212-983-9330 (Ext. 1310), or visit www.faruqilaw.com/PICS for more information.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/306282
Source: Faruqi & Faruqi LLP
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
